HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 18JUN21:06:47:1718JUN21:06:47:17 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS FAOT SASDATA 9.4 X64_SR12 18JUN21:06:47:1718JUN21:06:47:17 Findings About Events or Interventions HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002100000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study )FASEQ Sequence Number 2FATESTCDFindings About Test Short Name :$FATEST Findings About Test Name B'FAOBJ Object of the Observation f FACAT Category for Findings About FASCAT Subcategory for Findings About ž^FAORRES Result or Finding in Original Units ±^FASTRESCCharacter Result/Finding in Std Format FAEVAL Evaluator mVISITNUMVisit Number z"VISIT Visit Name ‚VISITDY Planned Study Day of Visit ¤EPOCH Epoch ¬FADTC Date/Time of Collection ÀFADY Study Day of Collection Ó1FATPT Planned Time Point Name ÛFATPTNUMPlanned Time Point Number HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T06:25:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:04:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T22:41:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:15:31B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T10:43:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T16:09:25CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T06:25:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:04:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T22:41:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:15:31B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T10:43:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1004US2011004E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T16:09:25CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:00:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:50:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:01:55BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T19:49:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:35:55B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:42:55BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T20:59:53BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T12:09:56CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:00:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:50:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:01:55BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T19:49:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:35:55B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:42:55BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T20:59:53BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1007US2011007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T12:09:56CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:15:34BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T16:37:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:03:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:21:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:12:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:15:34BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T16:37:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:03:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:21:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1009US2011009E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:12:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B¬ .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T17:42:18BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T14:15:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:02:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:06:27BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:20:03BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T15:08:26BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T07:37:28CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T17:42:18BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T14:15:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:02:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:06:27BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:20:03BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T15:08:26BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1011US2011011E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T07:37:28CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T08:40:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:25:57BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:46:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:51:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:56:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:02:31BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T04:30:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T17:08:06CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T08:40:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:25:57BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:46:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:51:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:56:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:02:31BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T04:30:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1012US2011012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T17:08:06CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T09:00:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:57:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:59:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:03:19B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:19:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:01:34BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:54:53CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T09:00:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:57:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:59:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:03:19B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:19:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:01:34BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1014US2011014E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:54:53CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T23:03:37BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:34:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:30:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:00:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T10:51:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T23:03:37BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:34:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:30:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:00:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T10:51:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ€OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Õ°OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕÀOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕÐOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕàOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÕðOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÖOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÖOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ö OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ö0OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ö@OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÖPOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ö`OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0ÖpOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1018US2011018E0Ö€OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T17:30:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T15:24:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:26:25BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T10:16:05CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T17:30:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T15:24:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:26:25BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1019US2011019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T10:16:05CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T01:52:00BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T07:03:41B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:17:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:10:43B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T17:59:22BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T14:07:32CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T01:52:00BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T07:03:41B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:17:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:10:43B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T17:59:22BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1020US2011020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T14:07:32CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:13:25BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:00:55B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:03:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T20:17:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T05:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T22:42:53BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:13:25BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:00:55B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:03:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T20:17:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T05:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1023US2011023E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T22:42:53BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-05 Bú .mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T10:37:19BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:39:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:54:22BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:11:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T04:58:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:00:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T06:32:21BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:21:13CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T10:37:19BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:39:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:54:22BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:11:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T04:58:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:00:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T06:32:21BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1028US2011028E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:21:13CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:01:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:51:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:34:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:11:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T13:32:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T15:06:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:01:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:51:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:34:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:11:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T13:32:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1029US2011029E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T15:06:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T07:16:34BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T14:39:54BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:55:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:46:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:09:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:49:27BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:54:15BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T07:16:34BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T14:39:54BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:55:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:46:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:09:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:49:27BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1030US2011030E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:54:15BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T08:01:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:24:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:25:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T03:50:27BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T01:21:51B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T17:20:15BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T09:36:39BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T07:51:23C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T08:01:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:24:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:25:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T03:50:27BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T01:21:51B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T17:20:15BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T09:36:39BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1032US2011032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T07:51:23C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-09 B¢ .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:17:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:06:53BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T18:17:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1039US2011039E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:06:53BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÔ .mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:25:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T02:54:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T03:28:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:58:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:10:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:25:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T02:54:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T03:28:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:58:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:10:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:25:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:58:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:25:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1040US2011040E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:58:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:16:08B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:20:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T12:41:40CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:16:08B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:20:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1041US2011041E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T12:41:40CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:58:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T13:48:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:25:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T13:57:06BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-14T18:15:58C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:58:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T13:48:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:25:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T13:57:06BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1042US2011042E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-14T18:15:58C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-22 Bì .mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T07:28:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:06:03BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:14:23B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T14:13:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:35:27B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:01:12BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:40:16CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T07:28:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:06:03BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:14:23B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T14:13:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:35:27B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:01:12BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1043US2011043E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T05:40:16CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:00:22BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:24:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T20:23:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T00:28:25BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:01:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:01:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:05:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T07:48:49CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:00:22BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:24:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T20:23:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T00:28:25BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:01:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:01:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:05:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1046US2011046E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T07:48:49CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:00:44BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:23:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:38:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:03:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T20:19:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:17:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T18:30:02BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T09:07:05CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:00:44BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:23:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:38:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:03:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T20:19:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:17:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T18:30:02BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1048US2011048E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T09:07:05CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T10:37:54BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:31:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:44:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:19:57B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T20:15:18B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:59:17BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T10:18:49BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T21:28:47C`DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T10:37:54BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:31:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:44:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:19:57B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T20:15:18B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:59:17BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T10:18:49BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1050US2011050E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T21:28:47C`DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕpOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ€OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Õ°OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T20:12:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T12:00:36BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:59:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:01:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T20:12:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T12:00:36BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:59:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:01:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö€OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0Ö°OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖÀOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖÐOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖàOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0ÖðOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0× OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×0OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×@OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×POCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×`OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×pOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1051US2011051E0×€OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:15:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T14:32:19BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T17:53:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T19:03:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T21:59:04B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T14:32:19BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T17:53:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T19:03:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1055US2011055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T21:59:04B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T07:04:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:00:25BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:12:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:05:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T11:38:16B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:00:12BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:16BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T06:46:48CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T07:04:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:00:25BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:12:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:05:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T11:38:16B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:00:12BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:16BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1056US2011056E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T06:46:48CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:12:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:58:53BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:25:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T21:36:36B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T10:54:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T20:11:38BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T11:16:10CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:12:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:58:53BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:25:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T21:36:36B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T10:54:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T20:11:38BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1057US2011057E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T11:16:10CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:09:08B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:49:38B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:09:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T11:51:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T11:04:53CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:09:08B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:49:38B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:09:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T11:51:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1059US2011059E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T11:04:53CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T23:09:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T20:33:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:51:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:38:21BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:45:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:01:05BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T11:06:51BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T12:00:31CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T23:09:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T20:33:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:51:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:38:21BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:45:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:01:05BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T11:06:51BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1060US2011060E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T12:00:31CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔpASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T19:02:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:06:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:08:52BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:48B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:30:03B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:41:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T07:10:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T08:06:52CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T19:02:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:06:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:08:52BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:48B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:30:03B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:41:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T07:10:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1061US2011061E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T08:06:52CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:18:10BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T23:14:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:34:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T19:12:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T23:24:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:52:23BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:43BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T08:55:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:18:10BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T23:14:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:34:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T19:12:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T23:24:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:52:23BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:43BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1064US2011064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T08:55:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:53:01BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T16:55:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:29:55BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T11:14:44BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:59:07B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T14:39:09BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:01:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T08:57:56CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:53:01BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T16:55:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:29:55BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T11:14:44BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:59:07B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T14:39:09BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:01:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1065US2011065E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T08:57:56CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô@ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔPASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô`ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B1 .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔpASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BA .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 B¡ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T18:16:23B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:56:16B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T18:16:23B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1067US2011067E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:56:16B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T00:01:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:08:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:24:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T11:07:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:25:43B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T09:23:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:02:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:02:40CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T00:01:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:08:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:24:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T11:07:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:25:43B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T09:23:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:02:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1068US2011068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:02:40CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T18:56:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T19:38:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:05:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:32:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:49:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T05:23:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T21:42:42BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T06:10:21CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T18:56:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T19:38:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:05:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:32:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:49:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T05:23:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T21:42:42BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1069US2011069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T06:10:21CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1070US2011070E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B? .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T01:51:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T02:26:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:05:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T02:39:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T18:08:53B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:04:05BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T05:23:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T03:07:44CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T01:51:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T02:26:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:05:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T02:39:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T18:08:53B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:04:05BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T05:23:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1080US2011080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T03:07:44CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T07:13:49BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:13:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:01:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T04:43:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:56:44B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:23:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T10:55:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T07:13:49BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:13:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:01:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T04:43:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:56:44B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:23:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1084US2011084E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T10:55:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:41:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T09:51:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:45:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:06:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:12:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:54:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T00:14:46CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:41:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T09:51:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:45:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:06:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:12:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:54:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1085US2011085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T00:14:46CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:26:11BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:01:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:54:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T01:51:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:01:18CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:26:11BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:01:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:54:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T01:51:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:01:18CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1086US2011086E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:46:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:03:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T16:32:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:08:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:31:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:31:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:35:46BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T10:44:22CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:03:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T16:32:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T18:08:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:31:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:31:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:35:46BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1087US2011087E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T10:44:22CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B> .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:50:55BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T10:27:59B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:01:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T18:33:20BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:50:55BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T10:27:59B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:01:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1088US2011088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T18:33:20BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BC .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:56:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T18:01:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T12:01:04BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T22:01:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T22:20:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:30:39BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T13:36:43CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:56:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T18:01:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T12:01:04BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T22:01:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T22:20:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:30:39BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T13:36:43CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:30:39BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1089US2011089E0ÖpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:30:39BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-21 Bè .mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:43:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:04:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:39:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:18:28BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T08:08:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:45:33BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:43:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:04:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:39:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:18:28BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T08:08:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1090US2011090E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:45:33BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B= .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕpOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ€OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B® .mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:24:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T17:59:35BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:33:15BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T15:13:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:24:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T17:59:35BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:33:15BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T15:13:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0Ö°OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖÀOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖÐOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖàOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0ÖðOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0× OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×0OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×@OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×POCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×`OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×pOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×€OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1091US2011091E0×OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:11:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B> .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T07:28:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:57:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T01:22:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:07:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T09:01:35BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:32:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T00:27:48CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T07:28:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:57:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T01:22:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:07:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T09:01:35BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:32:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1092US2011092E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T00:27:48CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T09:07:37BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T13:43:05BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T23:32:56B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T11:34:11BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:47:48B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T09:07:37BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T13:43:05BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T23:32:56B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T11:34:11BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1093US2011093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:47:48B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:02:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T17:59:42B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T08:28:06BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T11:11:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:59:26BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T20:31:10CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:02:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T17:59:42B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T08:28:06BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T11:11:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:59:26BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T20:31:10CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:02:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T11:11:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:02:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1095US2011095E0Õ NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T11:11:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T20:04:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:27:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:03:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:04:23B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:34:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:45:44BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T20:04:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:27:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:03:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:04:23B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:34:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1102US2011102E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:45:44BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:24:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T16:08:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:24:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:23:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T10:01:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:24:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T16:08:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:24:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:23:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1103US2011103E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T10:01:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T16:16:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T18:11:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T03:44:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:30:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:47:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T16:16:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T18:11:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T03:44:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:30:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1109US2011109E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:47:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:29:14BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T08:56:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:35:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-01T12:27:55B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:29:14BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T08:56:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:35:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1113US2011113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-01T12:27:55B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:23:14BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T08:59:11BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T14:46:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:36:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:50:01BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T16:37:13BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:23:14BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T08:59:11BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T14:46:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:36:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:50:01BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1114US2011114E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T16:37:13BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áð .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-27 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B& .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B- .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:01:01BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:04:08BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T18:13:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:08:30BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T17:42:36B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T19:02:08BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:01:01BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:04:08BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T18:13:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:08:30BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T17:42:36B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1116US2011116E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T19:02:08BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:43:38BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T19:10:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:50:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T16:46:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T18:07:22BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:43:38BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T19:10:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:50:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T16:46:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1117US2011117E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T18:07:22BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T18:31:30BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T18:43:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T15:07:05B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:57:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:34:00BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T06:24:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T18:31:30BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T18:43:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T15:07:05B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:57:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:34:00BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1118US2011118E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T06:24:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-27 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B& .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B- .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T08:34:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T21:24:28BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T00:02:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T12:00:32B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T07:18:43BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T21:23:43BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T08:34:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T21:24:28BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T00:02:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T12:00:32B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T07:18:43BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1120US2011120E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T21:23:43BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Â .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô€ASSESS Assessment Was the physical examination performed? Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T19:07:22BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T15:28:14B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T14:17:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T02:42:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T19:07:22BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T15:28:14B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T14:17:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1121US2011121E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T02:42:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Á .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T15:38:19BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T14:31:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T17:29:07BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T09:40:45BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T15:38:19BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T14:31:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T17:29:07BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1122US2011122E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T09:40:45BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Á .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T08:12:45BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:12:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:30:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:05:16BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:47:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:54:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T12:30:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T08:12:45BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:12:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:30:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:05:16BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:47:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:54:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1123US2011123E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T12:30:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Á .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:45:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T18:23:23BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T21:43:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T19:04:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T16:41:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T18:29:36BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:45:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T18:23:23BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T21:43:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T19:04:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T16:41:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1124US2011124E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T18:29:36BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áð .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B# .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:47:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:57:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:41:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:13:18B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T07:45:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T16:06:52BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:47:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:57:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:41:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:13:18B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T07:45:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1125US2011125E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T16:06:52BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:34:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:16:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T09:11:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:45:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:39:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T01:13:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T18:32:04BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:34:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:16:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T09:11:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:45:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:39:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T01:13:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1126US2011126E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T18:32:04BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bä .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔÀASSESS Assessment Was the physical examination performed? Y Y AàQë…¸PVisit 8 Day 209 Unscheduled 2 .PART A FOLLOW-UP 2021-03-09 C .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔÐOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ0OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ@OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕPOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ`OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕpOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ€OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T17:16:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T18:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T20:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T17:16:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T18:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T20:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T18:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T20:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T18:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T20:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ö°NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖÀNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖÐOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖàOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ÖðOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0× OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×0OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×@OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×POCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×`OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×pOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×€OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0× OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×°OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×ÀOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×ÐOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×àOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0×ðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø0OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø@OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØPOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø`OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØpOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø€OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0Ø°OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØÀOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØÐOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:31:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1127US2011127E0ØàOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:30:37BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B% .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B, .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:45:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:59:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T07:04:50B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:32:03BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:28:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T05:55:39BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:45:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:59:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T07:04:50B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:32:03BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:28:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1128US2011128E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T05:55:39BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:52:03BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:36:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T00:17:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:01:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:01:29B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:12:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T00:24:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:52:03BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:36:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T00:17:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:01:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:01:29B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:12:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1130US2011130E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T00:24:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:02:29BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:18BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:12:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:03:05BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T00:01:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:02:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T14:37:15BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:02:29BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:18BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:12:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:03:05BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T00:01:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:02:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1131US2011131E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T14:37:15BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19 B7 .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:35:02BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:47:04B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T23:28:14BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T17:34:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:40:48BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:35:02BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:47:04B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T23:28:14BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T17:34:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1137US2011137E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T14:40:48BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-27 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B- .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B= .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:18:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:03:42BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T18:18:02B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:34:34BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T22:23:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:18:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:03:42BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T18:18:02B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:34:34BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1138US2011138E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T22:23:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:55:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1139US2011139E0Ô COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:55:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Áp .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B& .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B- .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-28 BÖ .mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:03:02BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:38:48BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:06:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T12:00:30B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:03:02BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:38:48BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:06:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1142US2011142E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T12:00:30B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20 B8 .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T09:02:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:07:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:55:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:57:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T12:05:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T12:12:44BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T19:01:20BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T09:02:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:07:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:55:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:57:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T12:05:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T12:12:44BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1145US2011145E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T19:01:20BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:01:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T20:50:29BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:02:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:54:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:01:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T20:50:29BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:02:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1149US2011149E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:54:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:00:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:31:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T21:00:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:21:41BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:43:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:50:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:00:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:31:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T21:00:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:21:41BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:43:51B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1152US2011152E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:50:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-25 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:48:33BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:23:23BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:33:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:37:27BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T21:14:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T13:11:57BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:48:33BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:23:23BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:33:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:37:27BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T21:14:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T13:11:57BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T13:11:57BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1153US2011153E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-04T13:11:57BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:04:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:51:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:01:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:42:08B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:19:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T14:16:51BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T18:51:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:04:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:51:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:01:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:42:08B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:19:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T14:16:51BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1155US2011155E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T18:51:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:23:58BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:35:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:52:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:28:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T21:07:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:53:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T04:30:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:23:58BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:35:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:52:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:28:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T21:07:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:53:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1156US2011156E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T04:30:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂBLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B; .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-25 BÒ .mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:13:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:36:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:14:04BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:22:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:21:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:27:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T13:11:58BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:13:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:36:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:14:04BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:22:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:21:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:27:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1157US2011157E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T13:11:58BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:02:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:49:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:08:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T22:34:40BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T14:25:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T09:49:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T11:04:34BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:02:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:49:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:08:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T22:34:40BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T14:25:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T09:49:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US201-1159US2011159E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-09T11:04:34BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-02-01 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T06:50:42BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:54:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T19:00:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:13:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T18:01:47B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T06:50:42BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:54:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T19:00:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:13:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US201-1162US2011162E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T18:01:47B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:07:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:48:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:51:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:15:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:10:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:31:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T12:47:16CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:07:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:48:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:51:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:15:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:10:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:31:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T12:47:16CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:15:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0ÕHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:10:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:15:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1003US2021003E0Õ°NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:10:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-09 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BË .mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T05:18:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T08:27:54BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:52:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T12:10:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T04:14:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T07:25:33BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T09:59:15BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T05:46:32CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T05:18:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T08:27:54BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:52:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T12:10:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T04:14:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T07:25:33BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T09:59:15BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1004US2021004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T05:46:32CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1005US2021005E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B; .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:03:08BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:11:34BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:12:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:06:05BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T14:03:59B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T10:52:04BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T08:07:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:03:08BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:11:34BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:12:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:06:05BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T14:03:59B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T10:52:04BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1007US2021007E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T08:07:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1008US2021008E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US202-1009US2021009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21 B6 .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T16:01:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T23:30:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:21:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:03:24B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:45:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:47:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T13:22:49BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T16:01:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T23:30:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:21:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:03:24B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:45:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:47:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1011US2021011E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T13:22:49BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:12:20BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T13:07:43BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:34:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:11:08BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T07:13:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T11:08:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:12:20BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T13:07:43BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:34:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:11:08BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T07:13:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1012US2021012E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T11:08:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-09 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23 B8 .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T13:45:02BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:34:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:46:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:37:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T15:17:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T17:28:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T13:45:02BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:34:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:46:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:37:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T15:17:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1015US2021015E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T17:28:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-22 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29 B> .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BK .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 B× .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .BLINDED TREATMENT 2020-08-05T13:15:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:45:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:55:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T13:18:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:17:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T10:00:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .BLINDED TREATMENT 2020-08-05T13:15:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:45:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:55:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T13:18:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:17:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T10:00:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ö@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .BLINDED TREATMENT 2020-08-05T13:15:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÖPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:45:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:55:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÖpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .BLINDED TREATMENT 2020-08-05T13:15:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0Ö€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:45:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1018US2021018E0ÖNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:55:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-09 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B# .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bó .mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T16:37:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:54:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:18:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T16:37:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:54:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1019US2021019E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:18:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B; .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T23:55:18BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T10:33:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:39:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T21:00:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T03:59:45B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T14:29:58BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T23:55:18BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T10:33:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:39:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T21:00:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T03:59:45B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T14:29:58BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T21:00:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1020US2021020E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T21:00:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-22 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BË .mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T05:37:23BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:14:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:17:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:53:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:04:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:55:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T05:37:23BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:14:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:17:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:53:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:04:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:55:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:14:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1021US2021021E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:14:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B3 .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 BA .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:57:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:34:36B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T06:20:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T03:18:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:53:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:57:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:34:36B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T06:20:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T03:18:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1022US2021022E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:53:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1025US2021025E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1027US2021027E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:35:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:09:03BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:46:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:44:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:19:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:35:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:09:03BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:46:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:44:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1031US2021031E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:19:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1032US2021032E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1034US2021034E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1041US2021041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B; .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:48:53BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:03:16BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:45:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:03:42B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:55:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T03:56:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:48:53BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:03:16BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:45:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:03:42B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:55:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1043US2021043E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T03:56:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-02 B› .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:48:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:50:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:48:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T10:30:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:48:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:50:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:48:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T10:30:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1045US2021045E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24 B6 .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:08:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:53:48BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:19:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:45:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:02:08B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T06:19:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:08:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:53:48BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:19:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:45:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:02:08B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1047US2021047E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T06:19:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1051US2021051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1053US2021053E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1055US2021055E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1056US2021056E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1057US2021057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B1 .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:05:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:24:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:46:09B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T16:57:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:05:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:24:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:46:09B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1058US2021058E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T16:57:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T09:37:10BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:38:12BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:52:42BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:32:35BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:31:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:09:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:29:35BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T09:10:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T09:37:10BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:38:12BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:52:42BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:32:35BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:31:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:09:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:29:35BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1059US2021059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T09:10:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1060US2021060E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:04:33BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:57:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:37:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:08:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:50:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:59:06BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:04:33BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:57:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:37:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:08:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:50:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1061US2021061E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:59:06BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B6 .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-31 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-26 Bí .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕpOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ€OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T05:39:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:55:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:00:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:54:12BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:03:24BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T05:39:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:55:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:00:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:54:12BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1062US2021062E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:03:24BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B? .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BË .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bï .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bï .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bî .mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:53:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:19:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:55:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:02:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:53:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:19:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:55:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:02:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0ÖHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:02:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1063US2021063E0Ö NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:02:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 Bª .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔÀOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T16:47:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T11:42:17BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:07:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:29:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:37:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T10:17:38BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ0CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:57BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ@CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-14T11:00:53C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T16:47:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T11:42:17BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:07:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:29:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:37:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T10:17:38BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:57BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1064US2021064E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-14T11:00:53C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1065US2021065E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1066US2021066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B? .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:50:51B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:01:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:57:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:50:51B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:01:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1067US2021067E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:57:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 Bé .mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:52:19BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:21:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:47:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:25:42B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:12:32BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:52:19BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:21:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:47:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:25:42B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1068US2021068E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:12:32BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1071US2021071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1072US2021072E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-17 B© .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-09 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T06:22:54BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:06:29BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:35:08B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:39:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:12:38B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:01:14BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T06:22:54BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:06:29BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:35:08B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:39:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:12:38B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1073US2021073E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:01:14BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 Bá .mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:01:36BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:26:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:12:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:31:04B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T09:18:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:24:25BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:01:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:01:36BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:26:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:12:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:31:04B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T09:18:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:24:25BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1074US2021074E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-05T00:01:23CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1075US2021075E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:55:42BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:03:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:34:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:33:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:39:27BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:56:13BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:55:42BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:03:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:34:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:33:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:39:27BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1078US2021078E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:56:13BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1079US2021079E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:05:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:32:29B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:47:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:08:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:05:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:32:29B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:47:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1080US2021080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:08:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1081US2021081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B2 .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BB .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-10 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T01:23:55BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:03:51BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:01:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:01:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T00:02:27BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:08:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T01:23:55BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:03:51BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:01:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:01:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T00:02:27BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1082US2021082E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:08:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1083US2021083E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:44:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:55:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T11:01:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:26:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:51:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:40:20BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:44:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:55:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T11:01:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:26:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:51:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1084US2021084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:40:20BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1087US2021087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1088US2021088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T19:31:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T10:29:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T09:34:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T10:23:15BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:50:19B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:07:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T19:31:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T10:29:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T09:34:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T10:23:15BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:50:19B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1089US2021089E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:07:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T19:32:25BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:12:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:45:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T03:16:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:04:25BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T19:32:25BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:12:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:45:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T03:16:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1090US2021090E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:04:25BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BA .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T16:50:57BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:27:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:54:50BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T13:37:11B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T11:35:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:02:28BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T16:50:57BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:27:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:54:50BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T13:37:11B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T11:35:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1093US2021093E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:02:28BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔpASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-30 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Ô°OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS N N APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T08:41:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T16:11:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:54:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:18:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:57:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T02:17:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:01:37BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ0CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T00:02:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T08:41:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T16:11:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:54:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:18:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:57:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T02:17:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:01:37BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1094US2021094E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T00:02:41CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1095US2021095E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T22:27:14BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T22:05:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:31:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:18:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:29:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:25:39BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:05:53BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T22:27:14BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T22:05:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:31:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:18:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:29:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:25:39BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1096US2021096E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:05:53BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1097US2021097E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1098US2021098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-07 BC .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:22:15BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:10:41BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:49:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:13:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:56:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T16:16:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T16:27:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:22:15BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:10:41BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:49:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:13:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:56:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T16:16:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1099US2021099E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T16:27:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1100US2021100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T19:39:07BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:07:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:17:30B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T14:52:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:56:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T06:38:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T13:20:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T19:39:07BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:07:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:17:30B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T14:52:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:56:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T06:38:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1101US2021101E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T13:20:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1102US2021102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1105US2021105E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BØ .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 Be .mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:24:42BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:48:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T16:44:26BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:16:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:56:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:24:42BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:48:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T16:44:26BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:16:37BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:56:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0Ö°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0ÖðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0× OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×POCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1107US2021107E0×`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:01:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1109US2021109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1110US2021110E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-30 B5 .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-25 Bè .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:16:20BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:28:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:04:02BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:56:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T07:19:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:50:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:16:20BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:28:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:04:02BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:56:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T07:19:49BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:50:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0ÖPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:50:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1111US2021111E0Ö`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T18:50:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1113US2021113E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T19:58:53BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:00:48BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T09:51:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:53:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:12:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T19:58:53BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:00:48BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T09:51:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:53:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1114US2021114E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:12:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B2 .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:28:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:01:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:53:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:59:27B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:01:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:14:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T12:23:44BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:28:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:01:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:53:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:59:27B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:01:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:14:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1115US2021115E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-03T12:23:44BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1118US2021118E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1119US2021119E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1120US2021120E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-31 BÔ .mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T13:42:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:43:47BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:02:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:27B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:56:53BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T10:24:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T11:47:05CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T13:42:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:43:47BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:02:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:27B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T11:56:53BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T10:24:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1121US2021121E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T11:47:05CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1123US2021123E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1124US2021124E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1125US2021125E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1126US2021126E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1128US2021128E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô ASSESS Assessment Was the physical examination performed? Y Y A(õÂ\)Screening Unscheduled 1 .SCREENING 2020-06-05 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B? .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:38:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:36:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:18:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:43:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:55:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:38:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:36:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:18:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:43:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1130US2021130E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:55:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1131US2021131E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:57:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:36:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:21:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:11:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:57:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:36:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:21:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1133US2021133E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:11:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T20:30:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T21:53:26BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T02:46:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:10:13B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T09:55:12B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:20:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:03:41BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T20:30:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T21:53:26BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T02:46:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:10:13B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T09:55:12B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:20:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1135US2021135E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:03:41BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1136US2021136E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Áp .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 BH .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-31 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T16:32:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T01:37:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:57:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:41:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T07:48:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T01:30:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-15T12:00:12CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T16:32:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T01:37:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:57:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:41:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T07:48:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T01:30:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1137US2021137E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-15T12:00:12CDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BD .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-08 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:54:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:28:32BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:55:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:07:00B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:43:36BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:54:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T16:28:32BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:55:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:07:00B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:43:36BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖpOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö€OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0Ö°OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖÀOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖÐOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖàOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0ÖðOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0× OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×0OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×@OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×POCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×`OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1138US2021138E0×pOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:34:46BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1140US2021140E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1143US2021143E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô€ASSESS Assessment Was the physical examination performed? Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÖ .mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:02:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:03:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:30:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T13:38:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:28:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:01:17BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T07:45:27CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:02:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:03:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:30:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T13:38:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T06:28:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:01:17BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1144US2021144E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-08T07:45:27CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BF .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 Bà .mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:55:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:57:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:35:17BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:02:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:56:31BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:55:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:57:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:35:17BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:02:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:56:31BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:57:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:35:17BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:57:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1145US2021145E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:35:17BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1146US2021146E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¼ .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:05:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:03:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T04:44:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T09:14:13B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:55:16BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:26:30BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T09:30:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:05:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:03:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T04:44:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T09:14:13B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:55:16BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:26:30BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1147US2021147E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T09:30:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1148US2021148E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1149US2021149E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1150US2021150E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-18 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-25 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`(õÂ\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-23 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T00:02:42BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T00:01:33BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:58:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T01:44:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:57:19B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T03:49:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T00:02:42BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T00:01:33BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:58:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T01:44:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:57:19B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T03:49:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1151US2021151E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1152US2021152E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1153US2021153E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B2 .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BC .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 Bƒ .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:03:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:43:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:07:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:42:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:39:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:13:26BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:03:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:43:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:07:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:42:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:39:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1154US2021154E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:13:26BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BB .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 BÖ .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:52:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T13:25:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:00:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:36:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T23:03:15BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:57:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:52:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T13:25:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:00:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:36:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T23:03:15BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1155US2021155E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:57:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1156US2021156E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1157US2021157E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1158US2021158E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1159US2021159E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1160US2021160E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-16T08:13:41BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T17:25:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:46:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:22:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T18:58:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:01:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:03:50BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-16T08:13:41BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T17:25:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:46:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:22:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T18:58:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:01:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1161US2021161E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:03:50BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÜ .mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:22:55BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:24:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T09:16:28BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:43:03B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T12:00:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:38BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-11T08:21:29CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:22:55BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:24:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T09:16:28BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:43:03B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T12:00:56BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:38BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1162US2021162E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-11T08:21:29CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1163US2021163E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-10 A0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÜ .mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:24:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T12:51:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:54:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:01:16B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:05:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T06:12:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:24:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T12:51:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:54:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:01:16B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:05:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1164US2021164E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T06:12:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1165US2021165E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 Bá .mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:14:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:58:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:53:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:22:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T12:06:37BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:05:50BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-10T12:53:03CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:14:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:58:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:53:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:22:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T12:06:37BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T00:05:50BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1166US2021166E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-10T12:53:03CpDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T14:43:16BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:01:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T19:02:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T18:22:56BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:35:47B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T02:05:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T14:43:16BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:01:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T19:02:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T18:22:56BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:35:47B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1167US2021167E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T02:05:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1170US2021170E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1173US2021173E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1174US2021174E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÕ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 B€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T19:26:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:18:44BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T10:50:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:31:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:33:24B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:14:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:39BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T19:26:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:18:44BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T10:50:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:31:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:33:24B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:14:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1175US2021175E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:39BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1177US2021177E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1178US2021178E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-06 BÕ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕpOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ€OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B{ .mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T13:44:29BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:22:24BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:29:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T15:46:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:42:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T13:16:33BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T13:44:29BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:22:24BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:29:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T15:46:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:42:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1179US2021179E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T13:16:33BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 B× .mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:20:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:18:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:07:19BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T14:32:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:00:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T10:21:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:20:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:18:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:07:19BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T14:32:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:00:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1180US2021180E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T10:21:51BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1181US2021181E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B6 .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T16:41:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:01:18BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:18:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T09:51:44B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:07:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T12:04:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T16:41:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:01:18BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:18:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T09:51:44B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T09:07:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1182US2021182E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T12:04:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1183US2021183E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-08 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B5 .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:13:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:20:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T08:27:08BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:26:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:13:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:20:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T08:27:08BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1185US2021185E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:26:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:30:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:33:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:37:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:41:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:31:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:40:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:30:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:33:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:37:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:41:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:31:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1186US2021186E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:40:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1187US2021187E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1188US2021188E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-30 B¼ .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T10:00:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:38:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:17:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:44:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:54:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:52:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T10:00:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:38:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T16:17:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:44:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:54:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1189US2021189E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:52:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-03-02 Bú .mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:01:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:01:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:04:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:00B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:59:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:46:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T12:25:36BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:01:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:01:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:04:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:00B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:59:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:46:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1190US2021190E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T12:25:36BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bž .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T15:02:01BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:27:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:19:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T15:27:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:38:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:24:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T08:05:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T15:02:01BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:27:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:19:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T15:27:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:38:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:24:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1192US2021192E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T08:05:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1193US2021193E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1194US2021194E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B) .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:51:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:08:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:56:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:02:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T15:45:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:51:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:08:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:56:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:02:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1196US2021196E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T15:45:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Áà .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-12 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 BA .mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:29:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:16:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:14:15BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:01:15B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:29:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:16:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:14:15BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1198US2021198E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:01:15B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1201US2021201E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1202US2021006E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1202US2021202E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1203US2021203E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021035E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-03 Bß .mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:31:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:00:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T15:59:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:37:08B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:03:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:26:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T19:03:15BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:31:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:00:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T15:59:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T13:37:08B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:03:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:26:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1205US2021205E0Ö`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-02T19:03:15BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021029E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-26 Â% .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áð .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B" .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BE .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:10:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:32:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:57:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T08:00:06B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T15:50:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T16:22:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:10:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:32:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:57:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T08:00:06B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T15:50:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T16:22:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:32:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1206US2021206E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:32:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021104E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-28 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B1 .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 BF .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T13:04:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:40:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T09:14:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T07:50:41BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T21:01:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T13:04:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:40:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T09:14:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T07:50:41BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1207US2021207E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T21:01:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021044E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 Â# .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áà .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔpASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô€ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BF .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-07 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔÀASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔÐOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ0OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ@OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕPOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ`OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕpOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ€OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Õ°OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:38:35BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:49:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:53:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:27:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T05:31:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:38:35BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:49:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:53:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:27:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1208US2021208E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T05:31:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1209US2021046E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1209US2021209E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1210US2021042E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1210US2021210E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021010E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-26 Â% .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Áà .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-10 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:50:32BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:47:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:44:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:31:10BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:15:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:50:32BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:47:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:44:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:31:10BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1211US2021211E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:15:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1213US2021076E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021040E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20 B8 .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô ASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-11 BN .mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:00:52BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:36:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:36:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T14:37:50B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:08:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:00:52BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:36:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:36:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T14:37:50B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1214US2021214E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:08:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021070E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 Â! .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á° .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A° .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BH .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:29:48BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:01:39BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:47:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:02:25B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T12:52:23B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:29:48BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:01:39BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:47:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:02:25B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1215US2021215E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T12:52:23B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021039E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-27 Â$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-10 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:56:29BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:46:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:12:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:18:00B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:01:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:09:36BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:56:29BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:46:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:12:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:18:00B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:01:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1216US2021216E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:09:36BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Á .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B; .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T12:56:20BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:08:59BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:01:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T21:08:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T10:23:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T12:56:20BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:08:59BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:01:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T21:08:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1217US2021217E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T10:23:45B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021106E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-28 Â! .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Áp .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô ASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-12 Bi .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BË .mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:50:22BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:13:13BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:24:41B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:08:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T04:01:38B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T16:22:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:50:22BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:13:13BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:24:41B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:08:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T04:01:38B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1218US2021218E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T16:22:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021024E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-26 Â# .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Áp .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B. .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 BB .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:24:10BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:09:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T23:57:13B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:21:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T19:44:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:46:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:24:10BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:09:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T23:57:13B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:21:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T19:44:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1219US2021219E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:46:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021016E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-05-26 Â" .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B- .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:56:31BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:50:59BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T21:27:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:54:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T13:39:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T13:19:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:56:31BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:50:59BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T21:27:14B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:54:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T13:39:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1220US2021220E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T13:19:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1221US2021221E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021023E0ÔASSESS Assessment Was the physical examination performed? Y Y Previous Screening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô ASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-10 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔPASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B7 .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:08:03BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:50:35BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:01:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T08:53:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:11:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:08:03BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:50:35BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:01:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T08:53:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1222US2021222E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:11:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1225US2021225E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔÐOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÔðOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ0OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ@OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕPOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ`OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕpOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ€OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Õ°OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕÀOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕÐOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕàOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÕðOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö0OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö@OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖPOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö`CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:10:37BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:59:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:15:52B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:57:04B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:27:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0Ö°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:10:37BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:59:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T16:15:52B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:57:04B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1226US2021226E0ÖðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:27:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1228US2021228E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1229US2021229E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂBLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 Að .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-06 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-02-15 Bá .mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T11:44:44BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:53:39BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T08:34:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:26:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T15:27:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T11:44:44BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:53:39BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T08:34:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:26:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T15:27:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T11:44:44BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T11:44:44BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Õ°OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕÀOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕÐOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕàOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÕðOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÖOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÖOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö0OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö@OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÖPOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö`OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÖpOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö€OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0ÖOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1230US2021230E0Ö°OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T09:27:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1231US2021231E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-02 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-15 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10 BC .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 Bd .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T20:31:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:52:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:50:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T03:22:11B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:00:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T07:15:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T20:31:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:52:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:50:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T03:22:11B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:00:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T07:15:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:52:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1232US2021232E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:52:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1233US2021233E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-02 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-02 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A€ .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B$ .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B* .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B; .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:20:51BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T15:04:41BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T09:30:45B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T17:26:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:35:01B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-16T18:38:17BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:20:51BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T15:04:41BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T09:30:45B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T17:26:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:35:01B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US202-1234US2021234E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-16T18:38:17BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US202-1235US2021235E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-06 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1237US2021237E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-06 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1238US2021238E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-06 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1240US2021240E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-07 . .mRNA-1273-P201FAmRNA-1273-P201-US202-1241US2021241E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-07 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B> .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:17:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1001US2031001E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:17:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:11:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:42:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:10:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T04:51:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:01:52BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:53:21BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:11:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:42:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:10:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T04:51:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:01:52BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1002US2031002E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:53:21BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1003US2031003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-01 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B1 .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 BC .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-04 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:34:51B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:08:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T21:55:14BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:34:51B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:08:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1004US2031004E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T21:55:14BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1007US2031007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1008US2031008E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:01:01BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:57:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:45:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:33:23B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:01:01BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:57:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:45:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1009US2031009E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:33:23B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1010US2031010E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B1 .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 BE .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 Bà .mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T12:00:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T22:42:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T21:15:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:21:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T22:26:09BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T12:00:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T22:42:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T21:15:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:21:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T22:26:09BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0Ö°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0ÖðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0× OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×POCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1011US2031011E0×`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T12:18:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T20:26:58BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:52:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T19:42:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:24:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:28:11B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:59:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:58:33BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T20:26:58BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:52:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T19:42:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:24:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:28:11B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:59:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1012US2031012E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:58:33BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:43:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:00:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:35:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T18:34:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:18:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:40:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:43:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:00:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:35:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T18:34:13BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:18:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1013US2031013E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:40:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BË .mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:56:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:30:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:26:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T06:24:53BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:01:56BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:56:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:30:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:26:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T06:24:53BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1014US2031014E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:01:56BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1015US2031015E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B6 .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:43:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:27:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:52:28BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:43:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:27:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:52:28BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕPOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ`OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕpOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ€OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Õ°OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕÀOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕÐOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕàOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÕðOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÖOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÖOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ö OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ö0OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0Ö@OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1016US2031016E0ÖPOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1017US2031017E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1018US2031018E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B# .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B2 .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B? .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 B× .mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T10:39:53B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:01:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T14:51:41BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T12:00:46BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T10:39:53B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:01:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T14:51:41BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1019US2031019E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T12:00:46BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 BC .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T10:10:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:11:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T03:22:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:24:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:37:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T10:10:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:11:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T03:22:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:24:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1020US2031020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:37:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:09:42BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:52:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:29:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:09:42BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:52:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1021US2031021E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:29:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T08:38:51BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:51:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T08:38:51BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1022US2031022E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:51:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B# .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B* .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B1 .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:46:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T20:41:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:06:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T18:48:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T18:26:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:46:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T20:41:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:06:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T18:48:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1023US2031023E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T18:26:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1024US2031024E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T10:36:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:33:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T17:59:27B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T12:59:46BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:42B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:59:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:32:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T10:36:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:33:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T17:59:27B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T12:59:46BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:00:42B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:59:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1026US2031026E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:32:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T13:51:40BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:48:45BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T13:07:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:00:57BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T12:15:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T08:19:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T13:51:40BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:48:45BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T13:07:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:00:57BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T12:15:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1027US2031027E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T08:19:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1028US2031028E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T09:22:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T21:46:05BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:04:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:36:09BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:53:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T20:22:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T09:22:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T21:46:05BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:04:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:36:09BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:53:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1029US2031029E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T20:22:21BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:52:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:52:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T18:15:11B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:36:20BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T21:26:38B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T20:36:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T20:59:19BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:52:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:52:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T18:15:11B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:36:20BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T21:26:38B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T20:36:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1030US2031030E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T20:59:19BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1031US2031031E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T01:11:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:03:36B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:26:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T01:11:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:03:36B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1033US2031033E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:26:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1034US2031034E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ0OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ@OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕPOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ`OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕpOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ€OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Õ°OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕÀOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕÐOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕàOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÕðOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö0OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö@OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖPOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bj .mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö`CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T17:37:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:45:51B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T16:22:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T17:37:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0Ö°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:45:51B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T16:22:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖàHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ÖðNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0× OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×0OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×@OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×POCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×`OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×pOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×€OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0× OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×°OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×ÀOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×ÐOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×àOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0×ðOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1035US2031035E0ØOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T12:44:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1036US2031036E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:19:01BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:04:14BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T21:20:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:17:56B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:55:17BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:19:01BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:04:14BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T21:20:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:17:56B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1037US2031037E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T09:55:17BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BØ .mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T19:13:59BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:21:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T17:04:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T19:13:59BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:21:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1038US2031038E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T17:04:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1039US2031039E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:07:05BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T01:18:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:11:59BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:07:05BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T01:18:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:11:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1040US2031040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:11:59BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T22:02:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T21:39:46B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:07:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:50:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T04:59:51BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T22:02:15BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T21:39:46B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:07:48BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:50:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1041US2031041E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T04:59:51BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B= .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T00:04:12BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:32:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:21:31B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:02:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:00:18B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:01:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T00:04:12BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:32:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:21:31B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:02:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:00:18B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1042US2031042E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:01:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T18:41:09BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:16:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:09:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T18:41:09BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:16:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1043US2031043E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:09:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1044US2031044E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1045US2031045E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1045US2031045E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1045US2031045E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1045US2031045E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1045US2031045E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T08:37:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:33:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:21:45BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:13:51B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T04:00:55BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T08:37:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:33:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:21:45BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:13:51B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1047US2031047E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T04:00:55BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T14:06:37BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:12:47BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:41:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:02:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:01:18BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T14:06:37BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:12:47BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:41:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:02:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1048US2031048E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:01:18BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:10:58BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:09:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:01:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:37:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:10:58BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T00:02:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:09:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:01:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T05:37:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ€OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Õ°OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕÀOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕÐOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕàOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÕðOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÖOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÖOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ö OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ö0OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ö@OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÖPOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ö`OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0ÖpOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1049US2031049E0Ö€OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T14:04:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:47:37BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:52:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:02:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:06:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T09:01:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:47:37BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:52:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:02:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:06:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1050US2031050E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T09:01:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T00:02:12BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:04:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:44:58B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:31:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T10:11:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:57:10BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T19:39:26BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T00:02:12BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:04:24BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:44:58B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:31:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T10:11:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:57:10BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1051US2031051E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T19:39:26BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1052US2031052E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1053US2031053E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1055US2031055E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:13:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T09:25:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T18:18:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:34:08B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:13:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T09:25:27BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T18:18:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1056US2031056E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:34:08B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1057US2031057E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T17:03:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:49B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:00:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T18:00:42BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T17:03:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:49B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:00:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1058US2031058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T18:00:42BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B7 .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B¦ .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:37:07BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:11:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T02:09:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T03:51:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:02:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T19:40:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:39:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:37:07BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:11:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T02:09:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T03:51:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:02:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T19:40:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1060US2031060E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:39:52BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B7 .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:13:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T02:03:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:49:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:34:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T05:26:41BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:46:57BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:13:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T02:03:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:49:33B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:34:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T05:26:41BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1062US2031062E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:46:57BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:02:18BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T22:28:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:37:01BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:00:20B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:14:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T15:02:18BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T22:28:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:37:01BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:00:20B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1063US2031063E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:14:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1064US2031064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1065US2031065E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-13 B¥ .mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T06:35:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:18:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:20:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:03:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T06:35:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:18:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:20:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1066US2031066E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:03:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1067US2031067E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1068US2031068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1069US2031069E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-18 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:00:36BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:12:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T09:28:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T14:25:45B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:57:14BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:00:36BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:12:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T09:28:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T14:25:45B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1071US2031071E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:57:14BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B3 .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BB .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-19 Bª .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BË .mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:41:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:14:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:08:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:33:24BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T13:41:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:14:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:08:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:33:24BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕpOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ€OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Õ°OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕÀOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕÐOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕàOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÕðOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÖOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÖOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ö OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ö0OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ö@OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÖPOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0Ö`OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1072US2031072E0ÖpOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:05:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:24:53BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:39:35BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:08:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:39:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:24:53BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:39:35BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:08:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:39:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Õ°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÕðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÖOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÖOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ö OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ö0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ö@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0ÖPOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1073US2031073E0Ö`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T00:15:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T13:00:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:38:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:23:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:55:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:12:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:52:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T13:46:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T13:00:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:38:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:23:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:55:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:12:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:52:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1074US2031074E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T13:46:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1075US2031075E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1076US2031076E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1077US2031077E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1079US2031079E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B} .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:14:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:32:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:05:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:02:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T02:42:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:03:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:14:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:32:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:05:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:02:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T02:42:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1080US2031080E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:03:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B= .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-31 BY .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:55:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:10:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:05:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:48:05B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:33:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:55:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:10:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:05:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T14:48:05B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1081US2031081E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:33:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1082US2031082E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1083US2031083E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-20T10:50:02BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:35:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:13:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:58:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-11T06:38:07B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-20T09:11:31BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-20T10:50:02BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:35:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:13:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:58:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-11T06:38:07B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1084US2031084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-20T09:11:31BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T07:37:27BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:09:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T18:48:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T07:37:27BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:09:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1085US2031085E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T18:48:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-28 Bº .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:12:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:29:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:16:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T10:12:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:12:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:29:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:16:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T10:12:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Õ0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:12:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1086US2031086E0Õ@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:12:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B1 .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B? .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BË .mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:25:20BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T01:39:21BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:26:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:03:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T01:58:28BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:25:20BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T01:39:21BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T11:26:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:03:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1089US2031089E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T01:58:28BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1090US2031090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:23:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:28:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:30:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:59:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:15:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:59:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:23:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:28:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:30:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:59:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:15:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1091US2031091E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:59:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:49:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:41:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:49:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1092US2031092E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:41:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04 BB .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:00:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T19:02:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T16:27:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T17:59:45B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T13:58:39BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:00:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T19:02:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T16:27:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T17:59:45B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1093US2031093E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T13:58:39BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B6 .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T19:20:02BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T15:24:20B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T19:20:02BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1095US2031095E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T15:24:20B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:29:54BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:46:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:33:46B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:30:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:39:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:40:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:29:54BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:46:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:33:46B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:30:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:39:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1096US2031096E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:40:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B# .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B* .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 BA .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-28 BÕ .mRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:28:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1097US2031097E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:28:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:38:45BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:01:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:55:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:01:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T00:35:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:01:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:38:45BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:01:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:55:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:01:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T00:35:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1098US2031098E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:01:42BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1099US2031099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Aà .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19 B2 .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:32:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:41:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:45:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:54:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:14:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:17:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:32:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:41:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:45:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:54:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:14:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:17:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:54:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1100US2031100E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:54:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B3 .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 BA .mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T20:15:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:37:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T21:26:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T17:06:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:00:13B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:00:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T20:15:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:37:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T21:26:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T17:06:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:00:13B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1101US2031101E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:00:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25 BV .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T15:08:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T04:08:55BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T04:09:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T03:49:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T15:08:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T04:08:55BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T04:09:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1102US2031102E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T03:49:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T17:20:50BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:03:24BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T13:05:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:22:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T12:10:54B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T17:20:50BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:03:24BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T13:05:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:22:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1103US2031103E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T12:10:54B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B2 .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T12:48:55BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:59:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:59:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:01:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:15:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:10:00BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T12:48:55BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:59:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:59:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:01:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T07:15:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1104US2031104E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:10:00BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T21:15:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T11:27:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:05:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:03:13B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T19:50:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T21:15:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T11:27:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:05:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:03:13B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1105US2031105E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T19:50:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-02 Ap .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B? .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:43:44BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:01:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T19:59:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:32:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T03:43:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:01:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:43:44BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:01:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T19:59:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:32:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T03:43:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1106US2031106E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:01:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 BB .mRNA-1273-P201FAmRNA-1273-P201-US203-1107US2031107E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B6 .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:11:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T04:06:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T04:05:14B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T17:56:14BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:59:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:11:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T04:06:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T04:05:14B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T17:56:14BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1108US2031108E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:59:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:14:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:12:03BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:14:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1109US2031109E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:12:03BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:10:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:31:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:10:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1110US2031110E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:31:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B1 .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-02-01 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T14:15:44BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T13:03:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T16:21:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:11:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T14:15:44BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T13:03:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T16:21:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1111US2031111E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:11:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 BE .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:41:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T17:11:11BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T15:56:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T16:43:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:47:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T06:36:59BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T07:41:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T17:11:11BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T15:56:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T16:43:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:47:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1112US2031112E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T06:36:59BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B: .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:14:40BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:16:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:19:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:03:15B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T04:08:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:14:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:14:40BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T05:16:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:19:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T15:03:15B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T04:08:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1114US2031114E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:14:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1115US2031115E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B= .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 Bl .mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:45:20BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T10:10:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:47:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:02:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:45:20BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T10:10:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:47:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1116US2031116E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:02:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1119US2031119E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B* .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-26 Bw .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-24 B” .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:49:43B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1121US2031121E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:49:43B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:45:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:00:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T19:31:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:01:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T09:09:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:01:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:45:48BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:00:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T19:31:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:01:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T09:09:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1122US2031122E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:01:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:33:19BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:56:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:44:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:14:00BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T11:24:48B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T11:01:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:33:19BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:56:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:44:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:14:00BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T11:24:48B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1124US2031124E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T11:01:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B) .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T08:17:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:34:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T17:51:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:53:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:55:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T08:17:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:34:06BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T17:51:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:53:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1125US2031125E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:55:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1127US2031127E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B$ .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B+ .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:04:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:03:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:37:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:38:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T09:17:35BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:04:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:03:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:37:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:38:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1128US2031128E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T09:17:35BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á` .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B; .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T19:34:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1129US2031129E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T19:34:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1130US2031130E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T07:27:06BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:54:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T06:33:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:04:10BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T07:27:06BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:54:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T06:33:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US203-1131US2031131E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:04:10BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US203-1135US2031135E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-06 . .mRNA-1273-P201FAmRNA-1273-P201-US203-1136US2031136E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-07 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1001US2041001E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T07:11:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T22:30:45BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:39:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:26:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T07:11:58BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T22:30:45BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:39:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1002US2041002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:26:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T02:33:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:08:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T04:05:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:02:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:19:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-05T19:52:26C@DAY 307 C0mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T02:33:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:08:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T04:05:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:02:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:19:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1003US2041003E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-05T19:52:26C@DAY 307 C0mRNA-1273-P201FAmRNA-1273-P201-US204-1004US2041004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1005US2041005E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-13 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T22:45:40BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:07:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T11:49:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:15:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T14:30:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T20:51:06BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:58:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T22:45:40BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:07:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T11:49:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:15:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T14:30:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T20:51:06BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1006US2041006E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:58:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:59:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:28:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:11:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:19:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T18:09:42BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T11:18:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T04:59:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:28:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:11:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:19:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T18:09:42BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1007US2041007E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T11:18:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BH .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:40:55BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:23:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:24:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:26:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:59:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T16:35:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:40:55BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:23:05B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:24:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:26:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:59:56BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T16:35:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:24:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1008US2041008E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:24:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1009US2041009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:08:33BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:06:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:21:55BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:13:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:08:33BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:06:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:21:55BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:13:40BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Õ°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÕðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÖOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÖOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ö OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ö0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ö@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0ÖPOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1010US2041010E0Ö`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T11:35:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17 BN .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T22:48:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:13:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T14:08:31BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:06:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:47:27BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T16:53:58BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T22:48:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:13:06B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T14:08:31BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:06:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T15:47:27BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1011US2041011E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T16:53:58BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B4 .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BË .mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T04:54:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:09:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:12:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:28:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:36:15B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T18:55:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T21:46:17BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T04:54:27BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:09:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:12:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:28:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:36:15B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T18:55:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1012US2041012E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T21:46:17BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B) .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T20:56:00BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:50:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:02:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:24:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T20:56:00BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:50:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:02:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1013US2041013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:24:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B) .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-21 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:36:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T01:15:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:46:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:36:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T01:15:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1014US2041014E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:46:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1015US2041015E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BH .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔASSESS Assessment Was the physical examination performed? Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÐQë…¸PSafety Call Day 197 Unscheduled 2 .PART A FOLLOW-UP 2021-01-11 Bà .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:55:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:30:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:16:05BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:01:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:55:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:30:04BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:16:05BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1016US2041016E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:01:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1018US2041018E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BH .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:16:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:53:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:59:35BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:16:21B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:53:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1019US2041019E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T17:59:35BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:43:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:40:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:27:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T18:35:34BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T03:38:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:43:35B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:40:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:27:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T18:35:34BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1020US2041020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T03:38:54BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1021US2041021E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-05 Bš .mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T11:23:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:56:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T11:23:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:56:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕàHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÕðNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö0OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö@OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖPOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö`OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖpOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö€OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0Ö°OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖÀOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖÐOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖàOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0ÖðOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1022US2041022E0×OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:05:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-06 B€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T01:35:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:44:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T15:09:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T15:42:13BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T01:35:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:44:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T15:09:35BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T15:42:13BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö@OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖPOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö`OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖpOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö€OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0Ö°OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖÀOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖÐOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖàOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0ÖðOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0×OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0×OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0× OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0×0OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1023US2041023E0×@OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:13:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B7 .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-24 Br .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:00:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:50:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:55:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:00:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:50:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1024US2041024E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:55:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:02:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:54:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:02:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1025US2041025E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:54:53B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:03:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T18:50:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:11:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T18:17:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:45:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T04:53:23BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:03:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T18:50:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:11:22B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T18:17:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:45:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1026US2041026E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T04:53:23BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô ASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔÐOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÔðOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ0OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ@OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕPOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ`OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕpOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ€OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Õ°OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕÀOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕÐOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕàOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÕðOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö0OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö@OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖPOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-08 B¿ .mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:33:15BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:02:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:42:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:01:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0Ö°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:01:12BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:13:49BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:33:15BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T00:02:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0ÖðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:42:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0×COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:01:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0×COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T12:01:12BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1027US2041027E0× COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:13:49BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1028US2041028E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:13:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T23:43:09BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:06:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:13:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T23:43:09BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1029US2041029E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:06:53B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:57:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T15:15:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:45:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:57:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T15:15:07B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1030US2041030E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:45:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1031US2041031E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1032US2041032E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 BB .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 Bx .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:34:30B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:19:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T12:05:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T02:32:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:34:30B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:19:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T12:05:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1034US2041034E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T02:32:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1035US2041035E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-10 BF .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-19 BŒ .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T20:22:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:27:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:31:38B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:11:54BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T20:22:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:27:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:31:38B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:11:54BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1036US2041036E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T18:05:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:24:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:06:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:03:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:24:11B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:06:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:03:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1041US2041041E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:22:02B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:43:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:02:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:22:02B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:43:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1042US2041042E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T00:02:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1043US2041043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1043US2041043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1043US2041043E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B> .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:16:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1046US2041046E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:16:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô ASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-09 Bd .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T13:46:23BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T21:05:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T19:16:36B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:30:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:59:17B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T07:09:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:04:32BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T13:46:23BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T21:05:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T19:16:36B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:30:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:59:17B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T07:09:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1047US2041047E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:04:32BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B? .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô ASSESS Assessment Was the physical examination performed? Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔàOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ0OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ@OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕPOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ`OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕpOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ€OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Õ°OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕÀOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕÐOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕàOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÕðOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÖOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö0OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö@OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÖPOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-27 Bð .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-28 Bñ .mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:47:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:18:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:47:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1048US2041048E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:18:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-22 B1 .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28 B7 .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BE .mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:49:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T20:18:55BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:11:36BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T05:46:26BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:49:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T20:18:55BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:11:36BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1049US2041049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T05:46:26BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:03:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:15:25B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:10:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:50:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:57:33BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:16:27BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:03:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:15:25B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:10:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T08:50:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:57:33BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:16:27BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:10:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1051US2041051E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:10:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1052US2041052E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1052US2041052E0Ô ASSESS Assessment Was the physical examination performed? Y Y A(õÂ\)Screening Unscheduled 1 .SCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B4 .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BF .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BË .mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:45:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:20:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:36:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:28:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T23:42:55BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:27:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:45:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:20:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T22:36:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:28:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T23:42:55BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1053US2041053E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:27:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1054US2041054E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1055US2041055E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1055US2041055E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1055US2041055E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1055US2041055E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-25 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1055US2041055E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B; .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T19:14:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1056US2041056E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T19:14:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1057US2041057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1058US2041058E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US204-1058US2041058E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1058US2041058E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1058US2041058E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1058US2041058E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US204-1059US2041059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1059US2041059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1059US2041059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1059US2041059E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 BN .mRNA-1273-P201FAmRNA-1273-P201-US204-1060US2041060E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B3 .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:21:49B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T21:19:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T15:54:00BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:21:49B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T21:19:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1061US2041061E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T15:54:00BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:54:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:21:50B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:54:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1062US2041062E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:21:50B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1063US2041063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1064US2041064E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1065US2041065E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1066US2041066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1067US2041067E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1068US2041068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1070US2041070E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BC .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÝ .mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:43:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:27:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:30:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:52:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:43:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:27:47B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:30:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1071US2041071E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T12:52:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-05 B~ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:59:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:17:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:44:20BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T02:44:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T02:36:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T04:32:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:59:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:17:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:44:20BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T02:44:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T02:36:51BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1073US2041073E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T04:32:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1074US2041074E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:33:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:08:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:20:15B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T17:33:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:08:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1075US2041075E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:20:15B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 BA .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔASSESS Assessment Was the physical examination performed? Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-13 BI .mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:50:47BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:14:50B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T13:55:22BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T18:57:34BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:50:47BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:14:50B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T13:55:22BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T18:57:34BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:50:47BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:50:47BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0Ö°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0ÖðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0× OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×POCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1076US2041076E0×`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T16:06:47B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B7 .mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T11:31:46BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:14:14BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:07:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:01:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T02:00:57B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:53:19BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T12:02:42BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-07T13:07:11CPDAY 307 C0mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-05-02T18:28:10CàDAY 335 CðmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T11:31:46BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:14:14BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:07:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:01:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T02:00:57B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:53:19BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T12:02:42BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-07T13:07:11CPDAY 307 C0mRNA-1273-P201FAmRNA-1273-P201-US204-1077US2041077E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-05-02T18:28:10CàDAY 335 CðmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B; .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:55:42BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:03:00B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:30:37B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T07:57:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T08:18:08BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T06:01:38CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:55:42BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:03:00B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:30:37B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T07:57:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T08:18:08BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1078US2041078E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-06T06:01:38CPDAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B4 .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BB .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:35:49B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:05:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:58:50B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:01:03BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:02:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:35:49B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:05:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:58:50B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:01:03BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1079US2041079E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:02:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-05 BÙ .mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T21:08:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:57:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:01:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:09:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T21:08:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:57:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:01:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1080US2041080E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:09:24BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1081US2041081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1082US2041082E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B? .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-09 Bb .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T13:02:15BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:24:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:50:37B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T07:21:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T03:37:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:10:09BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T13:02:15BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:24:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:50:37B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T07:21:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T03:37:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1084US2041084E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T14:10:09BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1085US2041085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:08:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:00:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:29:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T11:13:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:08:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:00:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:29:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1086US2041086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T11:13:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1087US2041087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-29 Br .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-14 Bc .mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T13:53:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:43:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:00:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T17:59:55BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:14:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T13:53:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:43:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:00:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T17:59:55BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1088US2041088E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:14:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÔ .mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T14:04:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:51:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:19:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T06:18:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T06:10:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:58:24BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T14:04:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:51:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:19:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T06:18:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T06:10:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1089US2041089E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:58:24BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25 Bn .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T14:14:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T18:42:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:16:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T10:29:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T16:57:51BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T23:49:09BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T14:14:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T18:42:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T09:16:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T10:29:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T16:57:51BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1090US2041090E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T23:49:09BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B> .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25 Bl .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:04:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T07:16:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T18:40:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:13:55BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T16:57:01BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T08:45:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T07:04:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T07:16:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T18:40:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:13:55BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T16:57:01BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T08:45:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T07:16:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1091US2041091E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T07:16:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:11:39BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T12:10:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T19:47:55BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:29:22B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T21:35:50BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:11:39BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T12:10:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T19:47:55BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:29:22B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1092US2041092E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T21:35:50BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1093US2041093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-08 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:00:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:46:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T15:29:29BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:09:09B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T14:01:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:00:59BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:46:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T15:29:29BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:09:09B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1094US2041094E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T14:01:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:07:59BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1096US2041096E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:07:59BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1098US2041098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1099US2041099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-09 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:56:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:37:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:04:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:47:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T06:20:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:58:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:56:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:37:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:04:44B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:47:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T06:20:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1100US2041100E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:58:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T16:39:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1102US2041102E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T16:39:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T19:26:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1103US2041103E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T19:26:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-10 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T07:42:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:29:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T19:31:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T07:42:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:29:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1104US2041104E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T19:31:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1105US2041105E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Visit 1 Day 1 Unscheduled 1 .SCREENING 2020-06-29 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂBLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:08:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T12:54:35B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T17:08:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1106US2041106E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T12:54:35B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:54:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T18:57:50BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:54:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1107US2041107E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T18:57:50BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T11:54:57BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T23:21:23BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:59:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:16:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:46:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:06:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T11:54:57BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T23:21:23BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:59:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:16:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:46:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1108US2041108E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:06:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:26:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T07:00:09BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:37:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:22:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T14:08:58BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:26:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T07:00:09BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:37:21BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:22:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1109US2041109E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T14:08:58BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1110US2041110E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:47:05BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:01:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:38:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T10:01:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T09:08:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:47:05BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:01:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:38:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T10:01:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1111US2041111E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T09:08:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 BD .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T21:48:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T21:20:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:51:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T21:48:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T21:20:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1112US2041112E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:51:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bm .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-03 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Ô°ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-26 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T05:54:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:44:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T14:10:40B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T13:17:52BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T05:54:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:44:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T14:10:40B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1113US2041113E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T13:17:52BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-07 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 BD .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:24:56BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:12:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:01:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:01:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T17:06:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:24:56BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:12:03BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:01:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:01:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1114US2041114E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T17:06:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B# .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B1 .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B> .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-05 Ba .mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:25:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T18:00:15B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:20:28BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T06:58:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:30:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T07:14:51BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-06T17:59:41C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:25:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T18:00:15B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:20:28BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T06:58:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:30:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-07T07:14:51BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1115US2041115E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-04-06T17:59:41C€DAY 279 CpmRNA-1273-P201FAmRNA-1273-P201-US204-1116US2041116E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:01:55BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T12:36:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:02:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:17:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T13:19:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T12:01:55BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T12:36:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:02:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:17:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1117US2041117E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T13:19:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T20:25:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:42:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T06:08:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:01:14B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T04:34:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T20:25:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:42:29BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T06:08:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:01:14B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1118US2041118E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T04:34:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T18:18:16BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:20:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T16:56:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T19:41:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T17:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T18:18:16BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:20:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T16:56:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T19:41:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T17:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T19:41:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1119US2041119E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T19:41:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B* .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-22 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:59:03BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:08:14BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T10:04:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:59:03BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:08:14BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1120US2041120E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T10:04:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T06:16:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:36:36BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:23:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:04:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T02:18:17BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T22:18:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T06:16:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:36:36BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:23:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:04:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T02:18:17BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1121US2041121E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T22:18:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:43:29BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1122US2041122E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:43:29BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T17:59:44BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:16:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:40:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:02:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:13:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T17:59:44BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:16:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:40:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:02:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1123US2041123E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:13:13BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T01:31:41BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:45:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:30:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:01:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T00:07:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T01:31:41BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:45:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:30:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T00:01:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1125US2041125E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T00:07:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T21:48:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T09:13:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:35:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T21:49:24BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T21:48:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T09:13:52BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T06:35:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1126US2041126E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T21:49:24BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:49:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:15:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:55:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T17:26:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T20:11:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T08:49:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:15:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:55:29BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T17:26:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1127US2041127E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-03-01T20:11:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US204-1129US2041129E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-07 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T21:41:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:37:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T09:15:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:06:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T06:45:32BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T21:41:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:37:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T09:15:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:06:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1130US2041130E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-02T06:45:32BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Áà .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-17 B2 .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-15 BO .mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .BLINDED TREATMENT 2020-09-05T08:24:47BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:42:14BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:25:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T19:01:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:36:10BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .BLINDED TREATMENT 2020-09-05T08:24:47BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:42:14BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T07:25:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T19:01:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1131US2041131E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:36:10BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-21 BÒ .mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T16:32:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:53:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:49:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:07:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T16:32:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:53:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:49:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:07:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕpOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ€OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Õ°OCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕÀOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕÐOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕàOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÕðOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÖOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÖOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ö OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ö0OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ö@OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0ÖPOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1132US2041132E0Ö`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:25:44BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1133US2041133E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1134US2041134E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B" .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B) .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B1 .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B? .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T07:58:43BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:17:43BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:20:12B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:58:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T07:58:43BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:17:43BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:20:12B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1136US2041136E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:58:02B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1137US2041137E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Á .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-31 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:52:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:25:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:11:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:51:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:01:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T10:49:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T06:52:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:25:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:11:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:51:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T16:01:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1138US2041138E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T10:49:27BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:15:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:42:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:57:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:15:11BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:42:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1139US2041139E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:57:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1140US2041140E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1141US2041141E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T06:54:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:54:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:27:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:46:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T18:35:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T07:26:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T06:54:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:54:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:27:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:46:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T18:35:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1142US2041142E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T07:26:42BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1143US2041143E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Á .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:38:38BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T20:23:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:08:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:00:30BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:10:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T12:28:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:38:38BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T20:23:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:08:17B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T18:00:30BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T15:10:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1144US2041144E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T12:28:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T16:34:16BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T13:49:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T12:17:32BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T14:08:27B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T06:19:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:02:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T16:34:16BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T13:49:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T12:17:32BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T14:08:27B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T06:19:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:02:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:02:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1145US2041145E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:02:26BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áð .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B8 .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:04:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:49:35BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:31:44B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:04:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:49:35BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1146US2041146E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:31:44B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1147US2041147E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-15 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-12 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B; .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T16:47:51BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:05:51BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T21:18:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T23:36:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T19:33:02B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T16:47:51BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:05:51BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T21:18:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T23:36:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1149US2041149E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T19:33:02B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B" .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B3 .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B@ .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T21:21:31BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:02:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:02:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T21:21:31BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:02:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1150US2041150E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:02:20BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B, .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B: .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:32:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T14:48:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T16:33:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T05:43:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:55:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:32:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T14:48:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T16:33:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T05:43:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1151US2041151E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T05:55:14BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Â .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 Að .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B& .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B- .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B; .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-21 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T13:24:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T05:26:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:06:22B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T14:03:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T07:35:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T10:34:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T13:24:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T05:26:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:06:22B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T14:03:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T07:35:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T10:34:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T13:24:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1152US2041152E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T13:24:08BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1153US2041153E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1154US2041154E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T08:41:09BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T04:08:12BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T18:37:46B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T19:58:59B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T11:29:23BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T08:41:09BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T04:08:12BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T18:37:46B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T19:58:59B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1155US2041155E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T11:29:23BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1157US2041157E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US204-1158US2041158E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1160US2041160E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1161US2041161E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1162US2041162E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1164US2041164E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1165US2041165E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:02:57BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T14:29:59BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:59:02B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T19:58:50B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:10:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T07:50:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:02:57BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T14:29:59BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:59:02B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T19:58:50B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:10:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US204-1166US2041166E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T07:50:15BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US204-1167US2041167E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1168US2041168E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1169US2041169E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-02 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1170US2041170E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-07 . .mRNA-1273-P201FAmRNA-1273-P201-US204-1172US2041172E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-07 . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T19:17:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:00:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:30:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:40:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:24:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:01:28BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T19:17:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:00:34BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:30:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:40:40B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:24:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1001US2051001E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:01:28BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T15:16:51BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:06:41BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T11:30:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:34:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:42:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:42:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T15:16:51BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:06:41BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T11:30:57B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:34:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:42:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1002US2051002E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:42:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B= .mRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T11:08:17BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T23:03:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0Ô°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T11:08:17BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1003US2051003E0ÔÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T23:03:59BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B! .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T16:37:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T11:30:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:02:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T00:29:33B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:05:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T10:22:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-05T16:37:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T11:30:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:02:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T00:29:33B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:05:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1008US2051008E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T10:22:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T15:53:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:31:56BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:36:24B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:56B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T11:06:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:16:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:04:22BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T15:53:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:31:56BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:36:24B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:56B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T11:06:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T06:16:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1009US2051009E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:04:22BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02 B{ .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:10:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:54:42BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:24:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:00:14BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:54:24B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T17:28:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:16:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:10:35BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:54:42BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:24:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:00:14BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:54:24B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T17:28:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1010US2051010E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:16:42BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T13:04:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:00:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:00:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T03:50:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:00:33BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T14:06:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T13:04:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:00:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:00:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:00:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T03:50:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:00:33BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1011US2051011E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T14:06:05BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T10:54:46BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:05:50BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:08:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:36:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:23:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:01:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T10:54:46BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:05:50BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:08:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:36:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T00:23:07BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1012US2051012E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T00:01:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:54:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:51:50BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:21:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:00:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:22:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:00:17BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T12:54:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:51:50BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:21:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:00:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:22:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1013US2051013E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:00:17BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B7 .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T11:49:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:57:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T19:10:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T05:49:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T05:32:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T08:27:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:24:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T11:49:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:57:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T19:10:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T05:49:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T05:32:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T08:27:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1017US2051017E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T18:24:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-16T18:54:24BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T14:19:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T08:24:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:24:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T10:33:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T17:59:12BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:49:33BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-16T18:54:24BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T14:19:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T08:24:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:24:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T10:33:23BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T17:59:12BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1018US2051018E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:49:33BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B? .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-20T09:05:49BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:29:01BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T12:56:42BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T11:28:38BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:45:33B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-19T18:22:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-20T09:05:49BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:29:01BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T12:56:42BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T11:28:38BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:45:33B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1019US2051019E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-19T18:22:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B= .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:31:08BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:03:51BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:12:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:43:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T18:08:04B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T21:00:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:31:08BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:03:51BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:12:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:43:31BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T18:08:04B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1020US2051020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T21:00:31BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:34:50BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:56:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:30:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:47:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T05:55:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T07:25:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:08:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:34:50BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:56:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:30:08B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:47:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T05:55:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T07:25:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1022US2051022E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:08:35BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T08:53:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:02:30BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:55:12B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:16:43BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:56:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:15:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T05:44:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T08:53:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:02:30BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:55:12B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:16:43BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:56:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:15:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1024US2051024E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T05:44:27BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B# .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T19:34:49BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:15:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T19:14:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:01:25B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T14:03:08B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T19:03:27BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T16:59:06BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T19:34:49BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:15:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T19:14:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:01:25B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T14:03:08B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T19:03:27BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1025US2051025E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T16:59:06BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B@ .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T09:47:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:04:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T02:30:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:00:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T03:06:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T02:44:58BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T09:47:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:04:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:00:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T02:30:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:00:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T03:06:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1026US2051026E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T02:44:58BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B6 .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T11:55:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:00:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:01:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:02:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:00:24BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T11:55:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:00:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:01:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:02:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1027US2051027E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:00:24BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B6 .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T12:56:20BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T15:12:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:37B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T11:59:25BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:00:24B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T19:40:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:46:22BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T12:56:20BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T15:12:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:37B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T11:59:25BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:00:24B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T19:40:30BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1028US2051028E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:46:22BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-29 B” .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T21:41:45BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:36:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:31:47BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:38:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:05:43BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:16:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T21:41:45BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:36:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:31:47BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:38:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:05:43BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1029US2051029E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:16:59BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B? .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:54:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:59:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:03:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:04:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:48:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:19:25BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T07:30:55BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:54:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:59:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:03:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:04:00B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:48:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:19:25BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T07:30:55BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:59:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1030US2051030E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:59:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T07:48:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:14:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:33:46B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:15:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T21:18:47BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T07:48:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T10:14:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:33:46B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T07:15:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1031US2051031E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T21:18:47BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T00:01:31BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T23:15:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:21:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:08:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T21:57:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:59:29BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-09T00:01:31BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T23:15:16BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:21:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:30:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:08:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T21:57:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1032US2051032E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:59:29BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-10 B% .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B7 .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:49:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:14:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T12:38:43B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:02:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T18:03:24B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:10:14BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:27:43BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:49:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:14:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T12:38:43B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:02:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T18:03:24B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T18:10:14BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1033US2051033E0Õ€COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T12:27:43BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T11:33:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T10:21:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T11:43:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:24:17BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:34:46B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:01:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:06:32BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T11:33:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T10:21:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T11:43:38BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:24:17BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T14:34:46B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:01:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1034US2051034E0Ö`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T08:06:32BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B# .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-02 By .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-03 B\ .mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T06:26:05BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:15:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:38:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:17:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T06:26:05BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:15:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:38:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1035US2051035E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:17:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T12:49:10BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:27:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T00:12:52B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:43:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:12:54BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:42:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T12:49:10BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:27:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T00:12:52B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T08:43:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:12:54BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:42:28BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ€HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Õ°OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕÀOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕÐOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕàOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÕðOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÖOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÖOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö0OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö@OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÖPOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö`OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÖpOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö€OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0ÖOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1036US2051036E0Ö OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:02:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1038US2051038E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1038US2051038E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1038US2051038E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1038US2051038E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1038US2051038E0ÔPASSESS Assessment Was the physical examination performed? N N APVisit 4 Day 29 B . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔpASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô€ASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B> .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T23:23:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T13:33:46BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T01:50:20BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T23:23:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T13:33:46BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1040US2051040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T01:50:20BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:23:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T13:21:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:13:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:30:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:00:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:42:49BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:56:18BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T09:23:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T13:21:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T20:13:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:30:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:00:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:42:49BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1042US2051042E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:56:18BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B7 .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-16 Bˆ .mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T22:29:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:53:05BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:23:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:30:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T13:32:11BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:06:33BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T22:29:35BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:53:05BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:23:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:30:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T13:32:11BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1043US2051043E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:06:33BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B6 .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:56:47BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:36:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:36:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:29:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:57:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T13:03:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:56:47BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:36:31BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:36:28B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T12:29:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:57:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1044US2051044E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T13:03:18BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T12:10:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T17:43:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-15T17:26:39B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-09T11:10:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T12:10:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T17:43:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-15T17:26:39B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1045US2051045E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-09T11:10:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T09:02:17BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T04:24:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T07:22:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T09:08:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:53:29B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T08:34:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T00:04:02BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-17T09:02:17BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T04:24:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T07:22:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T09:08:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:53:29B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T08:34:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1048US2051048E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T00:04:02BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T00:54:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T16:18:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:12:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T19:37:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:39:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T15:42:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:36BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T00:54:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T16:18:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:12:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T19:37:38BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:39:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T15:42:19BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1050US2051050E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T12:00:36BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T09:21:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:17:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T19:35:13B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T17:02:44BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T12:21:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T18:42:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T09:21:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:17:04BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T19:35:13B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T17:02:44BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T12:21:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1054US2051054E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T18:42:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B# .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T08:27:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:00:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:31:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:48:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T08:19:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:31:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T08:27:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T13:00:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:31:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:48:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-25T08:19:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1055US2051055E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T07:31:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:43:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:31:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T07:03:23B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:47:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:43:24BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T12:31:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T07:03:23B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1057US2051057E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:47:53BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T21:22:26BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:29:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T18:00:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T16:39:18BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T21:22:26BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T14:29:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T18:00:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1059US2051059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T16:39:18BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T09:58:32BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:15:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:25:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T17:11:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:06:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T11:14:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T09:58:32BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T18:15:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:25:54B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-26T17:11:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:06:36BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1060US2051060E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T11:14:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Áà .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BË .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-10 B¤ .mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:13:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:40:04BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:40:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:52:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T13:06:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:53:45BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T16:13:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:40:04BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:40:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:52:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T13:06:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1063US2051063E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:53:45BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áà .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:46:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:17:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T10:30:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:05:55BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:46:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:17:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:19:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T10:30:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1064US2051064E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:05:55BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B6 .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T19:29:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:20:37BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:00:17B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:35:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:21:07B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T06:44:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T19:29:04BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T05:20:37BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T20:00:17B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:35:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:21:07B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T06:44:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:35:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1066US2051066E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T20:35:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:16:55BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:03:07BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:07:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T17:09:27BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:16:55BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:03:07BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T16:07:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1068US2051068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T17:09:27BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:00:23BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:20:05BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T07:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:21:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:37:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T13:00:23BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T10:20:05BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T07:23:04B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:21:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1069US2051069E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T08:37:50BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B" .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:54:20BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T22:22:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:02:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T11:26:57B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T19:54:20BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T22:22:16BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:02:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1070US2051070E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T11:26:57B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T10:06:03BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:07:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:36:33B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:56BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T09:02:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T00:33:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T10:06:03BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T11:07:24BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:36:33B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:56BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T09:02:14B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1071US2051071E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T00:33:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Â .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-21 BN .mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:38:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:10:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:43:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:59:15B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:38:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:10:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T09:43:21BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1072US2051072E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T07:59:15B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Â .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T19:13:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:01:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:04:43BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T14:54:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T10:13:10B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T19:13:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T12:01:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:04:43BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T14:54:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1073US2051073E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T10:13:10B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:53:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T21:48:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T15:53:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:18:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T18:00:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T05:54:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:53:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T21:48:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T15:53:25BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:18:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T18:00:58BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1074US2051074E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T05:54:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:47:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:33:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:38:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:19:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T09:44:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:47:38BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:33:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:38:01B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:19:46BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1075US2051075E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T09:44:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:47:39BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:59:49BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:48:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T15:54:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:07:09BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:47:39BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T11:59:49BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:48:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T15:54:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1077US2051077E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:07:09BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:22:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T19:42:31B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:32:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T12:06:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:41:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:22:11BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T19:42:31B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:32:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T12:06:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1078US2051078E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T08:41:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:54:30BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T23:19:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:33:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T16:23:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T19:22:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T21:04:50BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:54:30BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T23:19:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:33:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T16:23:21B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T19:22:28B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1081US2051081E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T21:04:50BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B@ .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T05:59:31BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:09:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:01:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T06:58:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T08:40:52B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:46:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T05:59:31BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:09:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:01:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T06:58:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T08:40:52B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1084US2051084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:46:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B> .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T11:59:06BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T07:26:32BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:28:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:10:09B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:24:57B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T13:26:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T11:59:06BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T07:26:32BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:28:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:10:09B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:24:57B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1085US2051085E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T13:26:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B, .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T18:21:11BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T18:40:11BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T18:00:05B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:04:02B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T18:21:11BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T18:40:11BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T18:00:05B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1086US2051086E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:04:02B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BA .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T06:09:45BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T07:12:52BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T16:57:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T08:32:01BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:23:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T06:09:45BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T07:12:52BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T16:57:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T08:32:01BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1087US2051087E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:23:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:43:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:35:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:44:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T09:03:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:05:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:43:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T07:35:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:40:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:44:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T09:03:30BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1088US2051088E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:05:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:05:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:05:59BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T21:39:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:41:42BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:46:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:05:02BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:05:59BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T21:39:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:41:42BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1089US2051089E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:46:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-26 Á° .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1092US2051092E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-26 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-01 BX .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-09 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:52:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:49:01BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T14:44:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T15:25:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:30:40B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T09:52:41BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T23:49:01BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T14:44:08BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T15:25:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1093US2051093E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:30:40B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:31:57BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T00:02:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T11:44:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T10:01:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T08:40:09B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:31:57BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T00:02:58BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T11:44:53B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T10:01:07B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1094US2051094E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T08:40:09B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B8 .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:46:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T07:48:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T07:52:09BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:23:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:46:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:46:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T07:48:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T07:52:09BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T08:23:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1095US2051095E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:46:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T01:52:17BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T21:34:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T03:35:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T20:37:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T13:56:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T01:52:17BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T21:34:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T03:35:29B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T20:37:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1096US2051096E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T13:56:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:31:56BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T11:15:10BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T18:06:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:42:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T18:35:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:31:56BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T11:15:10BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T18:06:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:42:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1097US2051097E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-03T18:35:41B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BA .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:38:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:35:49BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T08:53:15B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T20:49:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T09:08:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:38:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:35:49BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T08:53:15B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T20:49:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1098US2051098E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T09:08:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T23:45:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:36:50BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:50:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:30:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T10:35:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T23:45:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:36:50BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:50:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:30:59B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1099US2051099E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T10:35:38BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-29 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B" .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BE .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T02:15:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:48:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:01:03BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T01:06:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:27:43B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:51:09BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T02:15:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:48:44BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:01:03BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T01:06:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:27:43B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1100US2051100E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:51:09BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10 BC .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T06:34:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T10:21:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:43:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T06:33:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T00:10:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T00:17:59BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T06:34:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T10:21:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:43:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T06:33:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T00:10:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1101US2051101E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-13T00:17:59BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:00:40BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T09:22:19BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:40:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:55:29B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:00:40BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T09:22:19BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:40:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:55:29B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Õ HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:40:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Õ0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:55:29B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0Õ@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:40:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1102US2051102E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T10:55:29B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:43:29BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T06:59:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T21:05:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:06:43BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T21:10:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:43:29BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T06:59:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T21:05:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:06:43BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1103US2051103E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T21:10:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1104US2051104E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Áp .mRNA-1273-P201FAmRNA-1273-P201-US205-1104US2051104E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1104US2051104E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1104US2051104E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-30 B[ .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-04 Bœ .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:34:45BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T20:48:21BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:00:33BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T12:08:01BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T00:08:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:34:45BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T20:48:21BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:00:33BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T12:08:01BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1105US2051105E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T00:08:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T15:36:30BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T18:39:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:55:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:19:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T08:17:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T15:36:30BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T18:39:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T09:55:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:19:17B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1106US2051106E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T08:17:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:07:09BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:15:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:06:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:51:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T05:11:17BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:07:09BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:15:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:06:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:51:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1107US2051107E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T05:11:17BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BA .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-11 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-26 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T16:01:13BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T13:54:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T10:51:57B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T23:33:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:30:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T16:01:13BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T13:54:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T10:51:57B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T23:33:31B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1108US2051108E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T15:30:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B; .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T22:46:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T16:14:18BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:04:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T17:22:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T12:31:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T22:46:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T16:14:18BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:04:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T17:22:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T12:31:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1109US2051109E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:02:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T10:28:47BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T03:48:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:38:08B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T10:28:47BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T03:48:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1111US2051111E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T11:38:08B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T19:01:59BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:23:58BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T12:28:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T13:03:37BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T18:37:32B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T19:01:59BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:23:58BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T12:28:31BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T13:03:37BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T18:37:32B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:23:58BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T13:03:37BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:23:58BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US205-1112US2051112E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T13:03:37BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B% .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B> .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:13:08BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:13:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T20:59:55BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:49:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T05:45:40BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T12:13:08BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:13:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T20:59:55BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:49:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T05:45:40BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:13:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1001US2061001E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:13:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B! .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B= .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:53:17BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T15:35:11B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T14:12:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:46:32B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T14:38:00BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:40:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T18:53:17BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T15:35:11B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T14:12:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:46:32B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T14:38:00BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:40:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:40:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US206-1003US2061003E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:40:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T00:21:14BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:50:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T19:53:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:08:00BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:24:47B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:23:30BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T00:21:14BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:50:02BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T19:53:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:08:00BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:24:47B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1006US2061006E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:23:30BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B0 .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:46:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:54:21BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:17:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:08:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T16:43:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:07:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T18:46:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:54:21BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:17:40B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:08:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T16:43:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1008US2061008E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T10:07:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B? .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:56:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:02:16BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:19:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:28:48BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:56:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:02:16BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:19:26B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T18:28:48BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö@OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖPOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö`OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖpOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö€OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0Ö°OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖÀOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖÐOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖàOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0ÖðOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0×OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0×OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0× OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0×0OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1009US2061009E0×@OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:01:57B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B2 .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B? .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:57:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:48:55B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:01:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:02:44B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:26:15BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:57:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:48:55B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:01:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T19:02:44B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1010US2061010E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:26:15BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BE .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-25 Bs .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:58:40BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:12:44B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:33:35B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:06:23B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:06:58BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:58:40BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T15:12:44B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:33:35B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:06:23B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1011US2061011E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:06:58BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B= .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-29 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:25:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T10:14:05BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:04:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T07:00:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:37:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:34:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:25:57BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T10:14:05BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T11:04:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T07:00:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T17:37:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1013US2061013E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:34:20BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:02:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:08:59B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T13:03:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:12:18B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:18:25BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T18:02:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:08:59B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T13:03:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:12:18B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1015US2061015E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:18:25BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BE .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-01 B´ .mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:59:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T15:32:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:44:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:37:39B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T19:17:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T08:12:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T08:59:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T15:32:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:44:34B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:37:39B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T19:17:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1018US2061018E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T08:12:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-29 B9 .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-23 Bq .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-22 Bp .mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:42:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:32:26B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:05:20BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T00:04:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:33:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:42:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:32:26B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:05:20BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T00:04:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:33:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:42:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1019US2061019E0Ö0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:42:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T23:04:06BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T20:11:51BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T03:12:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:02:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T02:53:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T04:09:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T23:04:06BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T20:11:51BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T03:12:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:02:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T02:53:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1020US2061020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T04:09:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-30 B9 .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T19:48:50BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:48:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:38:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:33:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:26:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:10:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T19:48:50BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:48:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:38:07BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T05:33:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T05:26:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1021US2061021E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:10:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B8 .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T15:14:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T03:58:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T03:19:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T04:38:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:42:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T15:14:28BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T03:58:52B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T03:19:29B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T04:38:50BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1022US2061022E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:42:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-07 B} .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:56:53BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:01:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T18:52:50B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T00:08:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T08:11:12BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:56:53BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:01:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T18:52:50B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T00:08:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1023US2061023E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T08:11:12BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B? .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 Bµ .mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T21:02:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:11:06B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T20:30:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:31:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T21:02:13BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T20:11:06B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T20:30:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:31:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö@OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖPOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö`OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖpOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö€OCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0Ö°OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖÀOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖÐOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖàOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0ÖðOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0×OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0×OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0× OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0×0OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1024US2061024E0×@OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:06:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B; .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T16:35:59BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:29:25B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:15:34BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:45:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T19:05:49BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T16:35:59BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:29:25B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:15:34BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:45:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1025US2061025E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T19:05:49BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B= .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-16 Bh .mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:54:50BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:16:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T19:17:03BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T16:34:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:53:45BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:54:50BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:16:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T19:17:03BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T16:34:20B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1026US2061026E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T16:53:45BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B? .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T03:03:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:47:46B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:27:29BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T03:03:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T09:47:46B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1027US2061027E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T15:27:29BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B> .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:58:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:45:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T06:49:41B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T10:12:34B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T11:58:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:45:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T06:49:41B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1032US2061032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T10:12:34B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 B6 .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÁ .mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:45:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:27:31BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:19:57BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T19:03:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:45:10BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:27:31BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:19:57BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1035US2061035E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T19:03:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-11 B‹ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕpOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ€OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-11-14 BŽ .mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T20:49:57BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T15:33:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T17:38:21B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:22:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T08:20:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:36:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T20:49:57BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T15:33:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T17:38:21B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T07:22:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T08:20:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1036US2061036E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:36:39BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:58:33BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:46:51BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T10:11:45BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:44:03B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T20:34:14B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:58:33BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:46:51BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T10:11:45BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T12:44:03B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1037US2061037E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T20:34:14B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B6 .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:36:18BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:47:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T05:09:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T03:06:11B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T04:43:02BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T06:36:18BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:47:09BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T05:09:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T03:06:11B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1043US2061043E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T04:43:02BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-20 B5 .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:03:36BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:07:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:25:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T05:13:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T04:50:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:03:36BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T06:07:15BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:25:45B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T05:13:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1045US2061045E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T04:50:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-15 Bª .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ô°ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔÀOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:21:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T02:08:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:23:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:42:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:21:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T02:08:48BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T08:23:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T12:42:32BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕOCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Õ°OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕÀOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕÐOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕàOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÕðOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÖOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÖOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ö OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ö0OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ö@OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÖPOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ö`OCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÖpOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0Ö€OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1046US2061046E0ÖOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T07:07:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:03:39BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:47:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:43:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:23:30B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:03:39BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:47:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:43:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1051US2061051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:23:30B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B7 .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:06:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:04:33BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:07:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:12:15BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T10:10:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:06:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:04:33BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:07:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:12:15BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1053US2061053E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T10:10:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B$ .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:18:28BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T14:48:50BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:45:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:28:01B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T11:18:28BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T14:48:50BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:45:39B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1055US2061055E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T15:28:01B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B7 .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:03:56BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:15:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T07:46:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:56:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:03:56BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T15:15:57BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T07:46:22B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:59:49BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1057US2061057E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T08:56:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B? .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:07:08BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:01:01BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:48:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:07:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T16:49:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:48:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T18:07:08BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T18:01:01BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:48:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:07:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T16:49:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1063US2061063E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:48:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B8 .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T11:28:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T17:12:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:33:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:03:19BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T14:55:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T11:28:49BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T17:12:19BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:33:50B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:03:19BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1064US2061064E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T14:55:55B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔASSESS Assessment Was the physical examination performed? N N AScreening Â . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 BA .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:49:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:16:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:46:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:51:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:51:26B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:49:00BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T22:16:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:46:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:51:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US206-1068US2061068E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:51:26B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-22 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-05 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-10 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ0OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ@OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕPOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ`OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕpOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ€OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Õ°OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕÀOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕÐOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕàOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÕðOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö0OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A Safety Call Day 113 BqPART A FOLLOW-UP 2020-09-16 Bo .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö@OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AðSafety Call Day 237 BíPART A FOLLOW-UP 2021-01-19 Bì .mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖPCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T11:17:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö`CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T17:17:51BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:39:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:30:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ö°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T11:17:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T17:17:51BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T06:39:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÖðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T06:30:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0× HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×POCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×`OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×pOCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×€OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0× OCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×°OCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×ÀOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×ÐOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×àOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0×ðOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø0OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø@OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØPOCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø`OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØpOCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø€OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØOCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ø°OCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØÀOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØÐOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØàOCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ØðOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÙOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÙOCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ù OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ù0OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ù@OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0ÙPOCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T05:45:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1001US2071001E0Ù`OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:03:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-22 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-12 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:05:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T01:37:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:53:50BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:06:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T09:28:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:05:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T01:37:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T13:53:50BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T00:06:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:00:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T09:28:26BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:05:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1002US2071002E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T11:05:46BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-22 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-30 B· .mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:32:56BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T19:39:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:22:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T14:17:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:58:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:35:41BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T16:32:56BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T19:39:10BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T08:22:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T14:17:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:58:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1003US2071003E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:35:41BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Aà .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B1 .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-14 B… .mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T20:04:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:10:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:51:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:18:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:43:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:10:32BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T20:04:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:10:30BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T13:51:19B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:18:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:43:32BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1004US2071004E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:10:32BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B1 .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-28 BÒ .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-25 B± .mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:53:56BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T03:28:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T18:56:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:34:34B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:19:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:53:56BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T03:28:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T18:56:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:34:34B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:19:36BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ö HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T03:28:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1005US2071005E0Ö0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T03:28:20B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B8 .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÒ .mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T19:24:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:26:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T14:42:39B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:03:02BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:11:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T19:24:12BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T12:26:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T14:42:39B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:03:02BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1006US2071006E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T08:11:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T17:02:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:21:10B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:18:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:13:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:50:28BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T17:02:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:21:10B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T12:18:54B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T09:13:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1007US2071007E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T11:50:28BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BË .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-04 BØ .mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:26:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:22:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:15:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T05:10:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T06:57:00BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:26:41BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:22:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:15:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T05:10:46BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1012US2071012E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T06:57:00BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B? .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T01:18:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T01:24:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T23:34:29BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:32:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:17:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T01:18:45BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T01:24:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T23:34:29BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:32:39B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1013US2071013E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:17:22BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B? .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:28:56BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:53:18B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T16:37:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T23:34:22B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T11:57:30BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T18:28:56BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:53:18B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T16:37:02B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T23:34:22B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1014US2071014E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T11:57:30BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:28:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T00:08:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:17:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:24:27BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T00:01:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:28:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T00:08:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:17:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1016US2071016E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:24:27BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-25 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-18 BN .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BË .mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:20:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:17:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T15:28:46BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:31:57B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T14:34:52BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T18:20:37BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:17:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T15:28:46BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:31:57B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T14:34:52BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:31:57B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1017US2071017E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:31:57B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BA .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T03:53:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T04:38:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:22:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:18:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:56:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:13:55BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T03:53:32BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T04:38:22BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:22:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:18:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T14:56:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1022US2071022E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:13:55BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B1 .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T23:14:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:55:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:10:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:28:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:46:32BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T23:14:20BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T06:55:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:10:16B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T12:28:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1024US2071024E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T12:46:32BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:21:15BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:37:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:32:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:21:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:20:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:02:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-10T09:21:15BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:37:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:32:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:21:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T07:20:51BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1025US2071025E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T00:02:11BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô@ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔPASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô`ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30 B5 .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔpASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BB .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÔ .mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T08:02:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T16:30:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:45:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:07:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:01:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T12:00:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T08:02:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T16:30:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T06:45:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:07:52B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:01:43B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T12:00:16BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T08:02:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1026US2071026E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-15T08:02:03BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B5 .mRNA-1273-P201FAmRNA-1273-P201-US207-1029US2071029E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔpASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BF .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô€ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:34:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:43:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:21:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:37:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T23:02:40BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:34:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T07:43:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:21:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:37:22BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1030US2071030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T23:02:40BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-12 BB .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:18:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T12:30:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:53:37B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T16:57:17BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T10:16:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:18:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T12:30:27B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:53:37B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T12:00:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T16:57:17BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1032US2071032E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T10:16:46BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13 BC .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:38:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:38:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:55:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T15:54:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T11:58:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:38:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:38:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:55:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T15:54:33BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1033US2071033E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T11:58:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BA .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T11:42:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T00:01:18B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:09:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:38:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T11:42:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T00:01:18B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:09:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:38:37BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:22BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:09:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1036US2071036E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T00:09:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:38:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:57:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:04:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:58:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T12:38:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:57:58B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T18:04:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1037US2071037E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T08:58:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-29 B8 .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BE .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:20:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T14:05:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:06:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:03:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T07:16:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T12:20:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T14:05:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:06:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T12:03:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1038US2071038E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T07:16:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-30 B8 .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13 BF .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:09:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T01:04:51B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:58:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T03:24:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:21:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:09:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T01:04:51B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T17:58:19B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T03:24:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1039US2071039E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T16:21:57BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28 B3 .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T20:01:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T23:06:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T20:00:41B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T09:57:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T16:46:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T20:01:08BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T23:06:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T20:00:41B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T09:57:03B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1040US2071040E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T16:46:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-10 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-06 Bž .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ô°ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔÀOCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÔðOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ0OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ@OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕPOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-09 B‚ .mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:15:30BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:35:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T17:12:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:29:42B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:24:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:15:30BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:35:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T17:12:55B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:29:42B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:24:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ö0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:35:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1041US2071041E0Ö@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T09:35:50B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-21 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BA .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T07:37:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T20:47:58B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:35:46B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:41:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:02:00BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T07:37:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T20:47:58B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:35:46B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T18:41:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1042US2071042E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:02:00BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:05:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:02:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:49:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:47:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T04:52:05BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T11:05:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:02:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T11:49:25B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T08:47:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1043US2071043E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T04:52:05BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T14:14:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T12:03:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:18:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T12:22:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:50:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T08:23:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T14:14:32BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T12:03:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:18:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T12:22:42B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:50:53BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1044US2071044E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T08:23:47BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BE .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:01:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T00:01:35B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:03:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:01:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:01:33B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T00:01:35B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1046US2071046E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:03:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:01:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T04:31:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:58:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T09:15:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T00:01:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T04:31:32B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:58:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T00:01:43BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1049US2071049E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T09:15:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Aà .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-04 BÖ .mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:00:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:33:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:04:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:44:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:39:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:13:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:00:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:33:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:04:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:44:20B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:39:31BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1050US2071050E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:13:54BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:01:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:15:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T15:54:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:09:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T00:26:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T00:01:28BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:15:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T15:54:31B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T08:09:21BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1051US2071051E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T00:26:21BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T07:49:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T09:16:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:05:27B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:41:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T11:28:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T07:49:56BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T09:16:24B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:05:27B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T08:41:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1059US2071059E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T11:28:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 Bß .mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T00:43:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:36:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T00:01:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T23:41:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:10:02BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T00:43:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:36:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T00:01:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T23:41:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1062US2071062E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T00:10:02BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Aà .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B3 .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-13 Bà .mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T06:47:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:51:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:27:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T06:32:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T11:25:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T06:47:31BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:51:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:27:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T06:32:18BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1063US2071063E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T11:25:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 Bá .mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:01:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:12:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:50:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T06:12:18B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:24:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T17:06:41BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T12:01:13BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T06:12:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T08:50:49B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T06:12:18B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T06:24:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1064US2071064E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T17:06:41BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Aà .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô€ASSESS Assessment Was the physical examination performed? N N A€Visit 7 Day 57 B9 . .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T15:37:40BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T05:10:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T15:02:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:46:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T18:49:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T12:01:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T15:37:40BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T05:10:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-13T15:02:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:46:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T18:49:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1066US2071066E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T12:01:20BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-13 BF .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:35:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:06:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:53:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:15:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:33:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:35:26BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T00:06:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:53:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:15:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1067US2071067E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T15:33:01BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T11:29:25BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:27:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:27:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T05:38:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T19:05:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T19:26:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T11:29:25BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T05:27:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T05:27:53B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T05:38:56BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T19:05:48BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1068US2071068E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T19:26:45BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-28 B3 .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-17 BG .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:30:44BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:05:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:48:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-09T09:07:01B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:15:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:30:44BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:05:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:48:28B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-09T09:07:01B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1069US2071069E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T17:15:59BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ`OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕpOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ€OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-22 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:45:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T13:41:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:05:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:02:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T18:55:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T08:45:50BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T13:41:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:05:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:02:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T18:55:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÖPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:05:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T18:55:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0ÖpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:05:36B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1070US2071070E0Ö€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T18:55:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B1 .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BD .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:15:00BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:54:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:32:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:26:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T09:50:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:15:00BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:54:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:32:28B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:26:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1071US2071071E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T09:50:58BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô ASSESS Assessment Was the physical examination performed? Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-04 BÖ .mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:18:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:24:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:32:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:41:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T14:26:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:18:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T13:24:59B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:32:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:41:09BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1072US2071072E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T14:26:25BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B& .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T14:37:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T15:36:03BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:27:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T16:55:28BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T14:37:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T15:36:03BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T16:27:05B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1073US2071073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T16:55:28BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕPOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ`OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕpOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ€OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-09 B¹ .mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T14:40:17BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T00:01:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:51:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:52:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:32:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÕðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:34BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T14:40:17BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T00:01:46BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:51:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T06:52:36B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T00:32:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1074US2071074E0Ö`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:01:34BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-04 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T18:21:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:48:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T09:03:11BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T14:39:13BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T18:21:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:48:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T00:01:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-15T09:03:11BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1077US2071077E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T14:39:13BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:06:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:09:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T14:23:45BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:03:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T15:34:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:06:33BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:09:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T14:23:45BœDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:03:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1081US2071081E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T15:34:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:05:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T11:38:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:32:10BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:05:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T11:38:01B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:32:10BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Õ HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:05:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1082US2071082E0Õ0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T08:05:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T11:35:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T10:57:52B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:27:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:53:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T11:35:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T10:57:52B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:27:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:53:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Õ HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T11:35:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1083US2071083E0Õ0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T11:35:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:58:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:39:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:55:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:21:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:47:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:50:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:58:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T04:39:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:55:39B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T05:21:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T05:47:47BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1084US2071084E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:50:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T20:34:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:27:48B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:37:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:22:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T20:34:33BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:27:48B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:37:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1085US2071085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:22:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô0ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔPASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔpASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô€OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô OCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ô°OCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔÀOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔÐOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔàOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÔðOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕOCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ0OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A (õÂ\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-10 BŠ .mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T21:09:13BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T02:52:48BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T17:46:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:19:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Õ°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T21:09:13BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T02:52:48BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T17:46:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:19:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÕðHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T17:46:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÖHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:19:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0ÖNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T17:46:30B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1086US2071086E0Ö NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:19:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-30 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B2 .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-29 B` .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T16:38:30B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:33:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:53:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T16:38:30B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:33:15B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:53:25BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Õ0HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1087US2071087E0Õ@NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T00:04:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-08 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:55:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T09:52:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:19:24B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T04:37:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:55:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T09:52:28B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:19:24B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T04:37:34BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Õ HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:55:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1088US2071088E0Õ0NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T06:55:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B? .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:02:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T01:03:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:21:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:03:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:47:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T00:02:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T01:03:49BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T10:21:04B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T09:03:44B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1089US2071089E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:47:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T14:44:31BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:35:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:11:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T01:28:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T18:00:33B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T14:44:31BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:35:26BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:11:00B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T01:28:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1090US2071090E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T18:00:33B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-10 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-27 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:55:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T17:56:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T13:33:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:04:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:48:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:55:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-01T17:56:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-29T13:33:07B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:04:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1091US2071091E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T02:48:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-08 AÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-28 B! .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-05 B) .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-19 B7 .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔASSESS Assessment Was the physical examination performed? Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-16 B® .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-12 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-16 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T14:52:55BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:05:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:11:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:04:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:26:14BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-03T14:52:55BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T16:05:00BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T05:11:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T12:04:37B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1092US2071092E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T08:26:14BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B( .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 BA .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T16:47:13BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T19:49:43BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T20:05:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T18:01:12BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:28:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T16:47:13BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T19:49:43BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T20:05:15B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T18:01:12BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1093US2071093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T18:28:26BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Áà .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T08:38:36BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:47:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:46:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:35:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:24:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T08:38:36BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:47:17BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:46:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:35:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1094US2071094E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:24:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B+ .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B: .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:38:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:34:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:47:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:04:04B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T09:35:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:38:07BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:34:52BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:47:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T21:04:04B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1095US2071095E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-26T09:35:40BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Á€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-10 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05 B# .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21 B3 .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04 BA .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:47:30BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:06:23BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T05:38:06B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:31:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T13:11:40B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:47:30BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T09:06:23BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T05:38:06B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:31:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1096US2071096E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T13:11:40B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Áp .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B> .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:03:02BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T14:36:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T16:36:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:17:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T11:36:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:03:02BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T14:36:40BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T16:36:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:17:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1098US2071098E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T11:36:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-07 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-15 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 Að .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B* .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B; .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-08 B^ .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T10:06:34BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:41:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:24:00B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:48:37BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:58:54B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T10:06:34BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:41:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T13:24:00B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:48:37BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1099US2071099E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:58:54B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á° .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-04 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B. .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 B< .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T06:54:39BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:13:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:48:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:16:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T09:37:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T06:54:39BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T07:13:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:48:44BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:16:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1100US2071100E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T09:37:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1101US2071101E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A° .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-28 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-04 B% .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔpASSESS Assessment Was the physical examination performed? N N ApVisit 6 Day 43 B+ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T23:08:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:27:35BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:32:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:51:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T21:59:35B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T23:08:21BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T14:27:35BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:32:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T13:51:59B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T21:59:35B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:32:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1102US2071102E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T12:32:39BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂBLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-10 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-21 B3 .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-11 BH .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T21:13:19BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:14:55B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T20:00:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T21:48:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T21:13:19BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T00:14:55B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T20:00:10B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1103US2071103E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T21:48:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-26 Á .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-19 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04 B= .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-29 BV .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô ASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-28 BU .mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:17:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:53:55BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:47:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:11:14B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:29:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:17:25BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:53:55BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:47:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:11:14B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1104US2071104E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T11:29:21B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-30 Á` .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-19 B- .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-09 BB .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T07:06:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T12:14:09BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:56:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:03:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:08:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T07:06:59BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T12:14:09BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T12:56:23BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:03:34B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1105US2071105E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-02T07:08:07BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-07-01 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€PART A FOLLOW-UP 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Që…¸RVisit 2 Day 8 Unscheduled 2 .PART A FOLLOW-UP 2020-08-13 B' .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔPASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-18 B, .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B4 .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔpASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:11:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T11:29:01BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:08:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:52:56B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T13:31:51B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:11:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T11:29:01BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T11:08:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T11:52:56B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US207-1106US2071106E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T13:31:51B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-01 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-08 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-23 B8 .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T07:43:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T08:28:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:00:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:19:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T08:12:41BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:41:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-06T07:43:32BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T08:28:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:00:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T14:19:38B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:04:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T08:12:41BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1001US2081001E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T05:41:25BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-25 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-02 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-09 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-24 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-08 BÂ .mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T14:45:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:18:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:44:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T14:55:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T09:15:12BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-07T14:45:06BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:18:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T09:44:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T14:55:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1002US2081002E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T09:15:12BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:38:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:29:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:46:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:02:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T15:42:26BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T10:38:54BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T10:29:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T17:46:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T00:02:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1003US2081003E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T15:42:26BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T20:36:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:26:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T19:51:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T19:38:22BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T20:36:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:26:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T19:51:24BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1004US2081004E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T19:38:22BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-26 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:14:14BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:33:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:20:14BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:02:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:01:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:45:51BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:04:00BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-12T17:14:14BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T11:33:32BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T11:20:14BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:02:51BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T06:01:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T10:45:51BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1005US2081005E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T15:04:00BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:28:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:25:46BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:15:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:38:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:46:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:28:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T08:25:46BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T10:15:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:38:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1007US2081007E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T15:46:04B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-02 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T07:02:53BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:23:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T16:46:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:29:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T22:10:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:33:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:54:32BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-08T07:02:53BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T07:23:39BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T16:46:46BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T13:29:30B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T22:10:25B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:33:34BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1009US2081009E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T05:54:32BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T14:11:31BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:19:06BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:00:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:35:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:30:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:51:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:15:09BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T14:11:31BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T12:19:06BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T07:00:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T14:35:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T09:30:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T07:51:33BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1014US2081014E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T12:15:09BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-27 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-16 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:25:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:19:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:56:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T07:39:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T06:02:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:25:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T10:19:38B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T11:56:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T07:39:49BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1015US2081015E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T06:02:32BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-27 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-15 BÆ .mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:44:56BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:59:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:04:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:30:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:52:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T08:30:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T07:35:20BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T12:44:56BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-05T08:59:47BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-03T09:04:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-31T09:30:21B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T08:52:39BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-07T08:30:08BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1016US2081016E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T07:35:20BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T15:53:09BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:14:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:25:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:32:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:51:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:03:37BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:56:23BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T15:53:09BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T14:14:03BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:25:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:32:33B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T06:51:44BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T12:03:37BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1017US2081017E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:56:23BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-30 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-08 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÒ .mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T14:23:22BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:24:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T09:28:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:49:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:13:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T13:20:42BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T14:23:22BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:24:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T09:28:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:49:34B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T07:13:03BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1019US2081019E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T13:20:42BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-15 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-14 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:17:29BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:40:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:26:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:00:33B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:55:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T16:17:29BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:40:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T06:26:34B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T15:00:33B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:55:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:55:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:55:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Õ°OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕÀOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕÐOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕàOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÕðOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÖOCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÖOCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö0OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö@OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÖPOCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö`OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÖpOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö€OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0ÖOCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1020US2081020E0Ö OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T11:42:16B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:38:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:40:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:05:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:05:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:30:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T06:55:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:29:13BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:38:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T07:40:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:05:27BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T06:05:05B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T06:30:05BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-09T06:55:06BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1023US2081023E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T06:29:13BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-28 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B1 .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BA .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T16:08:51BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:47:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:20:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:29:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:19:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:49:03BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T16:08:51BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:47:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:20:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:29:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:19:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:49:03BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:20:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÕpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:29:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0Õ€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T08:20:30B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1025US2081025E0ÕNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T08:29:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:49:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T07:16:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:24:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T20:30:20B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T09:35:01B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:49:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T07:16:07BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:24:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T20:30:20B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1026US2081026E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T09:35:01B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BË .mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:14:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:39:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:53:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:29:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T13:00:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T23:00:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T08:14:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:39:31B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:53:05B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T10:29:42BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-10T13:00:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1028US2081028E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T23:00:12BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:45:54BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:02:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T18:40:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:13:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:30:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:50:32BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-13T17:45:54BIDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T00:02:02BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T18:40:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T12:13:47B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-08T13:30:03BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1029US2081029E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T11:50:32BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-16 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-06 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-13 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B1 .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-03 B? .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:27:36BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T17:36:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:50:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:23:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:00:40BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T09:27:36BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T17:36:13B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T05:50:11BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T13:23:45BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1030US2081030E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-11T07:00:40BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 BB .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-22 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:58:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:35:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:55:44B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:34:11B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:31BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T07:58:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T19:35:12B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T08:55:44B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T11:34:11B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1033US2081033E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T12:00:31BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-15 Aà .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-01 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-09 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-16 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-07-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T17:05:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:11:36BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:15:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:26:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:18:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:36:57BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-11T17:05:23BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T13:11:36BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:15:51BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T10:26:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:18:41B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1035US2081035E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T14:36:57BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-05-29 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A (õÂ\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-06 A0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔPASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô`ASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 Bâ .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔÐOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔàOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÔðOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ0OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ@OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-20 Bª .mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:18:45BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T15:04:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:06:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:01:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:05:29BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T06:30:30BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T18:18:45BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T15:04:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:06:25B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:01:38B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:05:29BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T06:30:30BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖpHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:05:29BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö€NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-12T12:05:29BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö OCCUR Occurrence Indicator Body aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0Ö°OCCUR Occurrence Indicator Chills SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖÀOCCUR Occurrence Indicator Congestion SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖÐOCCUR Occurrence Indicator Cough SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖàOCCUR Occurrence Indicator Diarrhea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0ÖðOCCUR Occurrence Indicator Difficulty breathing SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×OCCUR Occurrence Indicator Fatigue SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×OCCUR Occurrence Indicator Fever (Temperature >=100.4 F/38 C) SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0× OCCUR Occurrence Indicator Headache SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×0OCCUR Occurrence Indicator Muscle aches SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×@OCCUR Occurrence Indicator Nausea SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×POCCUR Occurrence Indicator New loss of smell SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×`OCCUR Occurrence Indicator New loss of taste SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×pOCCUR Occurrence Indicator Runny nose SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×€OCCUR Occurrence Indicator Shortness of breath SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0×OCCUR Occurrence Indicator Sore throat SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1036US2081036E0× OCCUR Occurrence Indicator Vomiting SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T12:11:17B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T13:24:58BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:36:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:36:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:38:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T06:16:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T18:05:56BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T13:31:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T13:24:58BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:36:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:36:42B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:38:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T06:16:52BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T18:05:56BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1038US2081038E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T13:31:49BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-26 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-04 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T11:52:18BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T16:02:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:11:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T11:10:36B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:22:16BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T11:52:18BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T16:02:35B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:11:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T11:10:36B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1039US2081039E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T00:22:16BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-11 BE .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ0OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ@OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕPOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ`OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕpOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ€OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Õ°OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕÀOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕÐOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕàOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÕðOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö0OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö@OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖPOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-21 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö`CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:19:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:53:58B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T09:43:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T16:00:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T07:56:16BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0Ö°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:19:46BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:53:58B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T09:43:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T16:00:40B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1041US2081041E0ÖðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T07:56:16BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-10 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-17 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BÛ .mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T12:11:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:06:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T10:29:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T19:30:36BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T11:30:14B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T10:39:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-19T12:11:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T12:06:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T10:29:59BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T19:30:36BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T11:30:14B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1042US2081042E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T10:39:53BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-01 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-04 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-11 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-18 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-07 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-20 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 BA .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-07 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T10:35:27BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:21:10BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:08:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T21:54:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:24:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T17:59:21BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:02:07BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T10:35:27BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:21:10BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T18:08:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T21:54:45B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T21:24:54BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T17:59:21BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1045US2081045E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T00:02:07BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á` .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-24 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 B× .mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:41:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:31:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:47:46B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T18:06:45BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:10:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T12:00:27BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:41:20BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:31:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:47:46B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-17T18:06:45BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1046US2081046E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-14T18:10:15BüDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B; .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T12:01:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T21:24:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:26:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T14:30:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:15:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T12:01:27BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-15T21:24:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-11T15:26:03B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-10T14:30:19B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1049US2081049E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T12:15:39B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-14 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 BC .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BØ .mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T09:59:23BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:07:58B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:02:55B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:56:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T10:07:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T09:59:23BeDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T12:07:58B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T10:02:55B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:56:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T10:07:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0Õ@HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T10:07:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1051US2081051E0ÕPNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T10:07:25BûDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-02 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B? .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-08 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ô°OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔÀOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔÐOCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔàOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÔðOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ0OCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ@OCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕPOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ`OCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕpOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ€OCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Õ°OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕÀOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕÐOCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕàOCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÕðOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö0OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y A°Safety Call Day 141 BPART A FOLLOW-UP 2020-10-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö@OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-27 B‘ .mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖPCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T11:21:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö`CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T14:34:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T16:38:34BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T16:42:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T11:21:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T14:34:26BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0Ö°COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T16:38:34BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T16:42:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖÐHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T11:21:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1052US2081052E0ÖàNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T11:21:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-21 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-28 BÏ .mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T10:29:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T05:13:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T20:15:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:20:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:10:17B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T12:00:15BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:07:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T10:29:12BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T05:13:07BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T20:15:27B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:20:26B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:10:17B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-13T12:00:15BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1054US2081054E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T06:07:00BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-03 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-05 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-12 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-19 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B1 .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-05 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-29 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T09:54:07BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:32:04BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:06:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:38:49B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T12:03:11B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T22:01:24BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-14T09:54:07BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:32:04BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T06:06:09B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:38:49B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T12:03:11B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1057US2081057E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T22:01:24BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô@ASSESS Assessment Was the physical examination performed? N N A@Visit 3 Day 15 Að . .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-06 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô`ASSESS Assessment Was the physical examination performed? N N A`Visit 5 Day 36 B$ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-21 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-21 BÅ .mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T12:12:49BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T17:06:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:24:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T09:32:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T13:48:08B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T10:20:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T12:12:49BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T17:06:01BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:24:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-08T09:32:54BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-06T13:48:08B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1058US2081058E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-14T10:20:12BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-04 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-16 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-13 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-20 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-27 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-10 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 Bá .mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:20:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:05:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:39:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T09:17:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:33:21BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-12T08:20:21BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T09:05:40BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:39:18B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T09:17:36B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1059US2081059E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:33:21BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-17 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-05 BÔ .mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T23:24:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T15:54:25BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T17:21:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T19:37:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T07:50:13B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T09:10:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:36:37BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T23:24:22BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T15:54:25BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T17:21:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T19:37:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T07:50:13B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-18T09:10:59BáDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1062US2081062E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:36:37BýDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-22 Að .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-08 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-15 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-22 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-06 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÚ .mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T08:35:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T14:43:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:53:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:04:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:31:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T12:04:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:05:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-08-18T08:35:23BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-13T14:43:51BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-10T08:53:29B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-07T07:04:57B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-05T07:31:11BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-16T12:04:16BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1063US2081063E0ÕpCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-11T09:05:03BùDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-05 Á0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-06-15 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-06-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-09 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô`ASSESS Assessment Was the physical examination performed? Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-10 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔpASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-16 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô€ASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-23 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-07 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-23 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:28:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:39:57BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T09:08:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:57:13B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T09:04:47BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:28:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:39:57BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T09:08:41B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T13:57:13B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-12T09:04:47BúDAY 251 BûmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0ÕPHLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:28:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1064US2081064E0Õ`NEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T09:28:58BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:23:05BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T21:49:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T11:23:24BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T03:23:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:57:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:02:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T07:23:05BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T21:49:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T11:23:24BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T03:23:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T09:57:01BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1065US2081065E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T00:02:45BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-09 Aà .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-11 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-25 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:53:43BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T08:52:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T11:15:14BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:13:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T12:40:47B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T09:49:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T05:53:43BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T08:52:38BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T11:15:14BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T10:13:43B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-24T12:40:47B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1066US2081066E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T09:49:31BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-11 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-24 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔASSESS Assessment Was the physical examination performed? Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-28 B_ .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô ASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-06 BÃ .mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:43:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T09:41:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T13:43:02BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:50:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T13:28:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:40:58BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T15:43:51BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T09:41:57BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T13:43:02BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:50:07B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T13:28:59BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1069US2081069E0Õ`COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-03T13:40:58BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T01:02:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:43:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:01:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T00:02:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T01:02:25BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T12:43:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:01:53B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T00:02:56B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1070US2081070E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T00:02:24BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-12 Â .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BË .mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:26:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:34:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T10:08:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:26:24B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T09:28:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:58:23BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T17:26:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T17:34:17BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T10:08:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T13:26:24B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T09:28:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1071US2081071E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T07:58:23BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T17:20:22BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:19:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:45:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T01:16:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:53:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-02T17:20:22BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T10:19:23BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T00:45:14B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T01:16:09B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1072US2081072E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T10:53:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Á° .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-03 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-24 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-03 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-10 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-21 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:04:36BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:19:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:14:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:39:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:44:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T11:04:36BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-30T07:19:40BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-28T07:14:23B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-25T08:39:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1073US2081073E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:44:15BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-15 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BË .mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:13:01BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:51:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:04:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T14:07:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T15:50:05BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T09:13:01BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T12:51:54BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T00:04:01B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T00:09:32B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T14:07:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1075US2081075E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-06T15:50:05BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-05 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-12 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B3 .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-03 BA .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-27 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:56:08BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:55:48BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T22:00:48B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:08:24BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:49:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:29:26BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:56:08BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T21:55:48BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T22:00:48B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T22:08:24BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:49:06BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1076US2081076E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T11:29:26BÞDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-16 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B# .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B? .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:10:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T09:22:09BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:52:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T17:21:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T10:58:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T22:10:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T09:22:09BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T09:52:41B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T17:21:49B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1077US2081077E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T10:58:25B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B; .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-15 BÇ .mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:04:58BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:51:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:29:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:49:50B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:24:13B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:49:03BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T09:04:58BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T10:51:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T10:29:36BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T12:49:50B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T11:24:13B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1080US2081080E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:49:03BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-17 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-27 BÕ .mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:11:16BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T16:12:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:16:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T05:27:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:14:46B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T07:52:02BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T14:11:16BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T16:12:32BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T10:16:16BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-28T05:27:23B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:14:46B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1081US2081081E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-04T07:52:02BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Áð .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-18 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26 B7 .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BD .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2020-12-17 B¨ .mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:46:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T08:35:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T11:07:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:08:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T09:18:52B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T07:53:32BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T08:46:19BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T08:35:43BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T11:07:00BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:08:43B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T09:18:52B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1085US2081085E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T07:53:32BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-11 BÄ .mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T16:32:41BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:48:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:14:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:29:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:13:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:56:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-06T16:32:41BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-04T08:48:25BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-01T16:14:47B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-29T16:29:26B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T07:13:19BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1087US2081087E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-05T06:56:46BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-18 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÉ .mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T08:59:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:10:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T08:55:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T07:26:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:35:19B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:02:00BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T08:59:17BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T12:10:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T08:55:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T07:26:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:35:19B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T11:02:00BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T07:26:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1088US2081088E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T07:26:35B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-02 B@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:28:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T06:00:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T20:39:36B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T11:28:17BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-01T11:57:57B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T19:16:17BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:28:21BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T06:00:28BdDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T20:39:36B€DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T11:28:17BDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-01T11:57:57B¹DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1090US2081090E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T19:16:17BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B' .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:55:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T23:33:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T21:42:49B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:07:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:33:37B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T11:16:47BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:55:10BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T23:33:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T21:42:49B~DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T10:07:54B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:33:37B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1091US2081091E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T11:16:47BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B: .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-21 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:49:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:42:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:12:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:07:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T13:36:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T14:15:36BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T10:49:19BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T08:42:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:12:26B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T10:07:12B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T13:36:48B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1092US2081092E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-09T14:15:36BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-19 ÁÐ .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-19 B1 .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:48:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T09:51:11BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:21:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T09:31:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:45:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:48:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T09:51:11BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:21:35BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T09:31:58B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1093US2081093E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T10:45:06B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-14 Aà .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B; .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÌ .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS Y Y ASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-24 BV .mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T21:19:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:48:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:06:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:56:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:47:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T21:19:00BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T16:48:46BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T09:06:38B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T10:56:48B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1097US2081097E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T07:47:48BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1098US2081098E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 . .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á@ .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-26 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-06 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-13 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-06 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-14 BË .mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:02:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T05:40:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T08:25:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T11:01:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:21:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:31:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-04T12:02:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-02T05:40:34BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-30T08:25:37BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-27T11:01:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-23T11:21:57BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1099US2081099E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-01T06:31:29BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-22 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B/ .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-10 BG .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T10:46:50BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:04:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:45:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:48:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T00:13:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T17:38:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T10:46:50BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T00:04:17BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:45:56B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:48:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T00:13:13BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1100US2081100E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T17:38:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-22 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ@OCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕPOCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ`OCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-22 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕpCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T07:40:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:51:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:08:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:27:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T04:04:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕÀCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T07:40:41BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕÐCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:51:41BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:08:11B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T09:27:04B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1103US2081103E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T04:04:08BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-06 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-13 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-20 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-01 B> .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-22 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:08:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:59:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:02:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:01:51B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T03:34:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T09:08:05BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T22:59:53BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T07:02:16B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T07:01:51B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1104US2081104E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T03:34:41BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-17 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-18 BÈ .mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T10:05:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:47:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:40:11BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:20:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:46:50B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-11T10:05:47BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T07:47:52BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T08:40:11BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T07:20:01B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1108US2081108E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:46:50B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1109US2081109E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 . .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-23 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-20 BÊ .mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:24:42BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T08:32:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:13:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T08:13:37B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T15:10:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:17:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T17:24:42BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T08:32:56BbDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T14:13:43B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-04T08:13:37B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T15:10:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1110US2081110E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T08:17:09BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Á .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-03 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A° .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-20 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-19 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-26 B7 .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-14 BJ .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-27 BÑ .mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T14:04:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:42:02BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T22:33:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:48:07B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T09:52:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-09T14:04:00BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-06T12:42:02BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T22:33:03B™DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T08:48:07B¶DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1112US2081112E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-10T09:52:08BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Áà .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-17 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-23 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B" .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-18 B* .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 B? .mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T07:40:42BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:03:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T12:09:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T10:13:19BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T13:35:59B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:51:45BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-16T07:40:42BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-14T21:03:30BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-11T12:09:28BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-08T10:13:19BšDAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-06T13:35:59B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1113US2081113E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-15T15:51:45BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1114US2081114E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 . .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-29 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô0ASSESS Assessment Was the physical examination performed? N N A0Visit 2 Day 8 A€ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-13 B. .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-27 B< .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-22 BÐ .mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T04:27:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:41:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:53:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:52:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:05:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T04:27:50BHDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-05T09:41:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-02T15:53:06BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-30T11:52:11B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1116US2081116E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-28T16:05:58B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-14 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-18 B, .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25 B3 .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BA .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-26 BÍ .mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T11:47:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:07:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:16:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:57:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:33:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T11:47:48BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T10:07:15BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T10:16:01BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:57:53B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1117US2081117E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T12:33:02B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-31 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-07 B& .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-14 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-28 B; .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-19 BË .mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:51:18BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:13:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:41:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:20:06B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T08:39:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:19:59BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T08:51:18BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:13:12BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:41:56BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T09:20:06B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T08:39:34B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1118US2081118E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T12:19:59BßDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-21 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11 B% .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-19 B- .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-25 B3 .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BA .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:47:18BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T16:34:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:45:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T06:45:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T08:29:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T13:47:18BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T16:34:18BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:45:54BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T06:45:08B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1119US2081119E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-04T08:29:31B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-01 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-09 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-16 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-05 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-12 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-26 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:07:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:03:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:44:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:35:27B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T09:17:35B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-07T08:07:40BEDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-07T11:03:42BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-04T09:44:49BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-02T10:35:27B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1120US2081120E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-30T09:17:35B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-24 ÁÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-06 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-13 A€ .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 AÀ .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-10 B$ .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-17 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24 B2 .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-04 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔASSESS Assessment Was the physical examination performed? N N AàVisit 8 Day 209 BÑ . .mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T19:54:04BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:37:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:29:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:48:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T10:59:09B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-14T19:54:04BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-12T08:37:22BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-09T08:29:58BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-07T08:48:12B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1121US2081121E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-01-05T10:59:09B¸DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1122US2081122E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 . .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 ÁP .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-30 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-15 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-11 B+ .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-08-19 B3 .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-25 B9 .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-09-08 BG .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-26 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô OCCUR Occurrence Indicator Anosmia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ô°OCCUR Occurrence Indicator Chest Tightness/Pressure COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔÀOCCUR Occurrence Indicator Chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔÐOCCUR Occurrence Indicator Cough COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔàOCCUR Occurrence Indicator COVID-19 COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÔðOCCUR Occurrence Indicator Dysgeusia COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕOCCUR Occurrence Indicator Fever COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕOCCUR Occurrence Indicator Headache COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ OCCUR Occurrence Indicator Lethargy COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ0OCCUR Occurrence Indicator Myalgia COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ@OCCUR Occurrence Indicator Other Symptoms COVID-19 SYMPTOMS Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕPOCCUR Occurrence Indicator Repeated Shaking with chills COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ`OCCUR Occurrence Indicator Shortness of Breath COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕpOCCUR Occurrence Indicator Sore Throat COVID-19 SYMPTOMS N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-29 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ€CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:24:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:43:06BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:01:34BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Õ°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:19:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:57:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T16:46:33BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-08T12:24:55BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÕðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T10:43:06BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T09:01:34BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0ÖCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-01T17:19:32B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ö COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-27T08:57:12BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1123US2081123E0Ö0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-08T16:46:33BàDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1124US2081124E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 . .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-11 B) .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-18 B0 .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:23:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:14:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:41:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:28:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T09:25:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔàCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-10T13:23:46BGDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÔðCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-08T10:14:47BcDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-05T10:41:19BDAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T12:28:40B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1125US2081125E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-31T09:25:29B·DAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 Áp .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô ASSESS Assessment Was the physical examination performed? Y Y A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-02 A .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô0ASSESS Assessment Was the physical examination performed? Y Y A0Visit 2 Day 8 A€BLINDED TREATMENT 2020-07-08 Ap .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô@ASSESS Assessment Was the physical examination performed? Y Y A@Visit 3 Day 15 AðBLINDED TREATMENT 2020-07-17 B .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔPASSESS Assessment Was the physical examination performed? Y Y APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-03 B! .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô`ASSESS Assessment Was the physical examination performed? Y Y A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-10 B( .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔpASSESS Assessment Was the physical examination performed? Y Y ApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-24 B6 .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô€ASSESS Assessment Was the physical examination performed? Y Y A€Visit 7 Day 57 B9PART A FOLLOW-UP 2020-08-31 B= .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔASSESS Assessment Was the physical examination performed? Y Y AàVisit 8 Day 209 BÑPART A FOLLOW-UP 2021-01-28 BÓ .mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:28:07BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Ô°CHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:32:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔÀCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:59:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔÐCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T13:53:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔàCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY Y Y STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:20:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÔðCHGHLTH Changes in health since last time FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:52:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-09-09T11:28:07BFDAY 71 BGmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÕCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-10-06T06:32:42BaDAY 99 BcmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Õ COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-11-03T06:59:55B}DAY 127 BmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Õ0COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-03T13:53:22B›DAY 155 B›mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Õ@COVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:20:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÕPCOVIDEXPExposure with SARS-CoV-2 or COVID-19FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2021-02-07T08:52:38BÝDAY 223 BßmRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0Õ`HLTHPCT Healthcare provided contact FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:20:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1129US2081129E0ÕpNEWSYMP Experience new symptoms of COVID-19 FOLLOW UP SAFETY SAFETY DIARY N N STUDY SUBJECT. .PART A FOLLOW-UP 2020-12-29T12:20:00BµDAY 183 B·mRNA-1273-P201FAmRNA-1273-P201-US208-1130US2081130E0ÔASSESS Assessment Was the physical examination performed? Y Y AScreening ÂSCREENING 2020-06-25 . .